Heterogeneous	O
expression	O
of	O
Epstein-Barr	B-protein
virus	I-protein
latent	I-protein
proteins	I-protein
in	O
endemic	O
Burkitt	O
's	O
lymphoma	O
.	O

Epstein-Barr	B-cell_type
virus	I-cell_type
(	I-cell_type
EBV	I-cell_type
)	I-cell_type
-infected	I-cell_type
cells	I-cell_type
may	O
sustain	O
three	O
distinct	O
forms	O
of	O
virus	O
latency	O
.	O

In	O
lymphoblastoid	B-cell_line
cell	I-cell_line
lines	I-cell_line
,	O
six	O
EBV-encoded	B-protein
nuclear	I-protein
antigens	I-protein
(	O
EBNA1	B-protein
,	I-protein
2	I-protein
,	I-protein
3A	I-protein
,	I-protein
3B	I-protein
,	I-protein
3C	I-protein
,	I-protein
-LP	I-protein
)	O
,	O
three	O
latent	B-protein
membrane	I-protein
proteins	I-protein
(	O
LMP1	B-protein
,	O
2A	B-protein
,	O
2B	B-protein
)	O
,	O
and	O
two	O
nuclear	B-RNA
RNAs	I-RNA
(	O
EBERs	B-RNA
)	O
are	O
expressed	O
.	O

This	O
form	O
of	O
latency	O
,	O
termed	O
latency	O
III	O
,	O
is	O
also	O
encountered	O
in	O
some	O
posttransplant	O
lymphoproliferative	O
disorders	O
.	O

In	O
EBV-positive	O
cases	O
of	O
Hodgkin	O
's	O
disease	O
,	O
the	O
EBERs	B-RNA
,	O
EBNA1	B-protein
,	O
and	O
the	O
LMPs	B-protein
are	O
expressed	O
(	O
latency	O
II	O
)	O
,	O
whereas	O
in	O
Burkitt	O
's	O
lymphoma	O
(	O
BL	O
)	O
only	O
the	O
EBERs	B-RNA
and	O
EBNA1	B-protein
have	O
been	O
detected	O
(	O
latency	O
I	O
)	O
.	O

We	O
have	O
studied	O
the	O
expression	O
of	O
EBV	B-protein
proteins	I-protein
in	O
17	O
cases	O
of	O
EBV-positive	O
endemic	O
BL	O
by	O
immunohistology	O
.	O

Expression	O
of	O
LMP1	B-protein
was	O
seen	O
in	O
variable	O
proportions	O
of	O
tumor	B-cell_type
cells	I-cell_type
in	O
two	O
cases	O
and	O
EBNA2	B-protein
was	O
detected	O
in	O
some	O
tumor	B-cell_type
cells	I-cell_type
in	O
three	O
other	O
cases	O
.	O

Also	O
,	O
the	O
BZLF1	B-protein
trans-activator	I-protein
protein	I-protein
was	O
expressed	O
in	O
a	O
few	O
tumor	B-cell_type
cells	I-cell_type
in	O
6	O
cases	O
,	O
indicating	O
entry	O
into	O
the	O
lytic	O
cycle	O
.	O

A	O
phenotypic	O
drift	O
from	O
latency	O
I	O
to	O
latency	O
III	O
has	O
been	O
observed	O
previously	O
in	O
some	O
BL	B-cell_line
cell	I-cell_line
lines	I-cell_line
.	O

Our	O
results	O
suggest	O
that	O
a	O
similar	O
phenomenon	O
may	O
occur	O
in	O
BL	O
in	O
vivo	O
and	O
indicate	O
that	O
the	O
operational	O
definition	O
of	O
EBV	O
latencies	O
is	O
not	O
easily	O
applied	O
to	O
human	O
tumors	O
.	O

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

Heterogeneous	NULL
Expression	NULL
of	NULL
Epstein-Barr	NULL
Virus	NULL
Latent	NULL
Proteins	NULL
in	NULL
Endemic	NULL
Burkitt	NULL
's	NULL
Lymphoma	NULL
By	NULL
G.	NULL
Niedobitek	NULL
,	NULL
A.	NULL
Agathanggelou	NULL
,	NULL
M.	NULL
Rowe	NULL
,	NULL
E.L.	NULL
Jones	NULL
,	NULL
D.B	NULL
.	NULL

Jones	NULL
,	NULL
P.	NULL
Turyaguma	NULL
,	NULL
J.	NULL
Oryema	NULL
,	NULL
D.H.	NULL
Wright	NULL
,	NULL
and	NULL
L.S	NULL
.	NULL

Young	NULL
Epstein-Barr	NULL
virus	NULL
(	NULL
EBV	NULL
}	NULL
-infected	NULL
cells	NULL
may	NULL
sustain	NULL
three	NULL
distinct	NULL
forms	NULL
of	NULL
virus	NULL
latency	NULL
.	NULL

In	NULL
lymphoblastoid	NULL
cell	NULL
lines	NULL
,	NULL
six	NULL
EBV-encoded	NULL
nuclear	NULL
antigens	NULL
(	NULL
EBNA1	NULL
,	NULL
2	NULL
,	NULL
3A	NULL
,	NULL
3B	NULL
,	NULL
3C	NULL
,	NULL
-LP	NULL
}	NULL
,	NULL
three	NULL
latent	NULL
membrane	NULL
proteins	NULL
(	NULL
LMP1	NULL
,	NULL
2A	NULL
,	NULL
2B	NULL
)	NULL
,	NULL
and	NULL
two	NULL
nuclear	NULL
RNAs	NULL
(	NULL
EBERs	NULL
)	NULL
are	NULL
expressed	NULL
.	NULL

This	NULL
form	NULL
of	NULL
latency	NULL
,	NULL
termed	NULL
latency	NULL
III	NULL
,	NULL
is	NULL
also	NULL
encountered	NULL
in	NULL
some	NULL
posttransplant	NULL
lymphoproliferative	NULL
disorders	NULL
.	NULL

In	NULL
EBV-positive	NULL
cases	NULL
of	NULL
Hodgkin	NULL
's	NULL
disease	NULL
,	NULL
the	NULL
EBERs	NULL
,	NULL
EBNA1	NULL
,	NULL
and	NULL
the	NULL
LMPs	NULL
are	NULL
expressed	NULL
(	NULL
latency	NULL
II	NULL
)	NULL
,	NULL
whereas	NULL
in	NULL
Burkitt	NULL
's	NULL
lymphoma	NULL
(	NULL
BL	NULL
)	NULL
only	NULL
the	NULL
EBERs	NULL
and	NULL
EBNA1	NULL
have	NULL
been	NULL
detected	NULL
{	NULL
latency	NULL
i	NULL
)	NULL
.	NULL

We	NULL
have	NULL
studied	NULL
the	NULL
expression	NULL
of	NULL
EBV	NULL
proteins	NULL
in	NULL
17	NULL
cases	NULL
HE	NULL
EPSTEIN-BARR	NULL
VIRUS	NULL
(	NULL
EBV	NULL
)	NULL
is	NULL
associated	NULL
with	NULL
a	NULL
variety	NULL
of	NULL
lymphoid	NULL
and	NULL
epithelial	NULL
neoplasms	NULL
,	NULL
including	NULL
Burkitt	NULL
's	NULL
lymphoma	NULL
(	NULL
BL	NULL
)	NULL
,	NULL
``	NULL
Hodgkin	NULL
's	NULL
disease	NULL
(	NULL
HD	NULL
)	NULL
,	NULL
``	NULL
posttransplant	NULL
lymphoproliferative	NULL
disorders	NULL
(	NULL
PTLD	NULL
)	NULL
,	NULL
*	NULL
``	NULL
and	NULL
undifferentiated	NULL
nasopharyngeal	NULL
carcinomas	NULL
(	NULL
NPC	NULL
)	NULL
.	NULL

``	NULL
*°	NULL
In	NULL
these	NULL
tumors	NULL
,	NULL
monoclonal	NULL
viral	NULL
genomes	NULL
have	NULL
been	NULL
identified	NULL
in	NULL
virtually	NULL
all	NULL
tumor	NULL
cells	NULL
indicating	NULL
that	NULL
EBV	NULL
infection	NULL
takes	NULL
place	NULL
early	NULL
in	NULL
the	NULL
neoplastic	NULL
process	NULL
and	NULL
suggesting	NULL
an	NULL
important	NULL
role	NULL
for	NULL
the	NULL
virus	NULL
in	NULL
tumor	NULL
development	NULL
.	NULL

``	NULL
``	NULL
**	NULL
The	NULL
nature	NULL
of	NULL
the	NULL
contribution	NULL
of	NULL
EBV	NULL
,	NULL
however	NULL
,	NULL
remains	NULL
uncertain	NULL
.	NULL

Studies	NULL
of	NULL
EBV	NULL
gene	NULL
expression	NULL
in	NULL
virus	NULL
carrying	NULL
cell	NULL
lines	NULL
and	NULL
in	NULL
human	NULL
tumor	NULL
biopsy	NULL
specimens	NULL
have	NULL
identified	NULL
three	NULL
distinct	NULL
forms	NULL
of	NULL
virus	NULL
latency	NULL
.	NULL

Lymphoblastoid	NULL
cell	NULL
lines	NULL
(	NULL
LCL	NULL
s	NULL
)	NULL
,	NULL
generated	NULL
by	NULL
in	NULL
vitro	NULL
immortalization	NULL
of	NULL
B	NULL
lymphocytes	NULL
with	NULL
EBV	NULL
,	NULL
express	NULL
an	NULL
array	NULL
of	NULL
virus-encoded	NULL
proteins	NULL
including	NULL
six	NULL
nuclear	NULL
antigens	NULL
(	NULL
EBNA1	NULL
,	NULL
2	NULL
,	NULL
3A	NULL
,	NULL
3B	NULL
,	NULL
3C	NULL
,	NULL
-leader	NULL
protein	NULL
[	NULL
LP	NULL
]	NULL
)	NULL
and	NULL
three	NULL
latent	NULL
membrane	NULL
proteins	NULL
(	NULL
LMP1	NULL
,	NULL
2A	NULL
,	NULL
2B	NULL
)	NULL
.	NULL
``	NULL

The	NULL
small	NULL
EBV-encoded	NULL
nonpolyadenyl-ated	NULL
nuclear	NULL
RNAs	NULL
(	NULL
EBER1	NULL
and	NULL
2	NULL
)	NULL
are	NULL
also	NULL
expressed	NULL
at	NULL
high	NULL
copy	NULL
numbers	NULL
in	NULL
these	NULL
cells	NULL
.	NULL
``	NULL

In	NULL
LCLs	NULL
,	NULL
all	NULL
six	NULL
EBNAs	NULL
are	NULL
generated	NULL
by	NULL
differential	NULL
splicing	NULL
of	NULL
a	NULL
single	NULL
large	NULL
primary	NULL
RNA	NULL
transcript	NULL
originating	NULL
from	NULL
one	NULL
of	NULL
two	NULL
promoters	NULL
located	NULL
at	NULL
the	NULL
left	NULL
end	NULL
of	NULL
the	NULL
linear	NULL
viral	NULL
genome	NULL
in	NULL
the	NULL
BamHI	NULL
C	NULL
or	NULL
BamHI	NULL
W	NULL
fragments	NULL
(	NULL
Cp	NULL
or	NULL
Wp	NULL
)	NULL
.°	NULL
This	NULL
form	NULL
of	NULL
virus	NULL
latency	NULL
,	NULL
termed	NULL
latency	NULL
(	NULL
Lat	NULL
)	NULL
III	NULL
,	NULL
is	NULL
also	NULL
observed	NULL
in	NULL
human	NULL
PTLDs	NULL
.	NULL

!	NULL

'*	NULL
``	NULL
~	NULL
``	NULL
EBV	NULL
gene	NULL
expression	NULL
in	NULL
other	NULL
human	NULL
tumors	NULL
is	NULL
more	NULL
re-stricted	NULL
.	NULL

In	NULL
EBV-positive	NULL
cases	NULL
of	NULL
HD	NULL
and	NULL
in	NULL
a	NULL
proportion	NULL
of	NULL
undifferentiated	NULL
NPCs	NULL
,	NULL
EBNA1	NULL
,	NULL
the	NULL
LMPs	NULL
and	NULL
the	NULL
EBERs	NULL
are	NULL
expressed	NULL
,	NULL
but	NULL
none	NULL
of	NULL
the	NULL
other	NULL
EBNA	NULL
proteins	NULL
are	NULL
detected	NULL
;	NULL
this	NULL
form	NULL
of	NULL
infection	NULL
has	NULL
been	NULL
termed	NULL
Lat	NULL
II	NULL
.	NULL

*	NULL
``	NULL
*°	NULL
An	NULL
even	NULL
more	NULL
restricted	NULL
form	NULL
of	NULL
EBV	NULL
latency	NULL
,	NULL
termed	NULL
Lat	NULL
I	NULL
,	NULL
has	NULL
been	NULL
observed	NULL
in	NULL
BL	NULL
.	NULL

Thus	NULL
,	NULL
Western	NULL
and	NULL
Northern	NULL
blot	NULL
studies	NULL
of	NULL
BL	NULL
cell	NULL
lines	NULL
and	NULL
of	NULL
a	NULL
very	NULL
limited	NULL
number	NULL
of	NULL
fresh	NULL
BL	NULL
biopsy	NULL
specimens	NULL
have	NULL
demonstrated	NULL
the	NULL
expression	NULL
of	NULL
EBNA1	NULL
and	NULL
the	NULL
EBERs	NULL
only	NULL
.	NULL
``	NULL

''	NULL
In	NULL
Lat	NULL
I	NULL
and	NULL
Lat	NULL
II	NULL
,	NULL
EBNA1	NULL
transcription	NULL
originates	NULL
from	NULL
a	NULL
different	NULL
promoter	NULL
located	NULL
closer	NULL
to	NULL
the	NULL
EBNA1	NULL
open	NULL
reading	NULL
frame	NULL
in	NULL
the	NULL
BamHI	NULL
F	NULL
fragment	NULL
of	NULL
the	NULL
EBV	NULL
genome	NULL
(	NULL
Fp	NULL
)	NULL
.	NULL

Tumor	NULL
cells	NULL
of	NULL
endemic	NULL
BL	NULL
are	NULL
not	NULL
susceptible	NULL
to	NULL
killing	NULL
by	NULL
EBV-specific	NULL
cytotoxic	NULL
T	NULL
cells	NULL
,	NULL
and	NULL
certain	NULL
phenotypic	NULL
features	NULL
of	NULL
BL	NULL
cells	NULL
have	NULL
been	NULL
used	NULL
to	NULL
explain	NULL
this	NULL
phenome-non	NULL
.	NULL

BL	NULL
cells	NULL
display	NULL
a	NULL
downregulated	NULL
expression	NULL
of	NULL
adhesion	NULL
molecules	NULL
such	NULL
as	NULL
lymphocyte	NULL
function-associated	NULL
anti	NULL
Blood	NULL
,	NULL
Vol	NULL
86	NULL
,	NULL
No	NULL
2	NULL
(	NULL
July	NULL
15	NULL
)	NULL
,	NULL
1995	NULL
:	NULL
pp	NULL
659-665	NULL
of	NULL
EBV-positive	NULL
endemic	NULL
BL	NULL
by	NULL
immunohistology	NULL
.	NULL

Expression	NULL
of	NULL
LMP1	NULL
was	NULL
seen	NULL
in	NULL
variable	NULL
proportions	NULL
of	NULL
tumor	NULL
cells	NULL
in	NULL
two	NULL
cases	NULL
and	NULL
EBNA2	NULL
was	NULL
detected	NULL
in	NULL
some	NULL
tumor	NULL
cells	NULL
in	NULL
three	NULL
other	NULL
cases	NULL
.	NULL

Also	NULL
,	NULL
the	NULL
BZLF1	NULL
trans-activator	NULL
protein	NULL
was	NULL
expressed	NULL
in	NULL
a	NULL
few	NULL
tumor	NULL
cells	NULL
in	NULL
6	NULL
cases	NULL
,	NULL
indicating	NULL
entry	NULL
into	NULL
the	NULL
lytic	NULL
cycle	NULL
.	NULL

A	NULL
phenotypic	NULL
drift	NULL
from	NULL
latency	NULL
|	NULL
to	NULL
latency	NULL
III	NULL
has	NULL
been	NULL
observed	NULL
previously	NULL
in	NULL
some	NULL
BL	NULL
cell	NULL
lines	NULL
.	NULL

Our	NULL
results	NULL
suggest	NULL
that	NULL
a	NULL
similar	NULL
phenomenon	NULL
may	NULL
occur	NULL
in	NULL
BL	NULL
in	NULL
vivo	NULL
and	NULL
indicate	NULL
that	NULL
the	NULL
operational	NULL
definition	NULL
of	NULL
EBV	NULL
latencies	NULL
is	NULL
not	NULL
easily	NULL
applied	NULL
to	NULL
human	NULL
tumors	NULL
.	NULL

©	NULL
1995	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
.	NULL

gen	NULL
3	NULL
(	NULL
LFA-3	NULL
)	NULL
and	NULL
intercellular	NULL
adhesion	NULL
molecule-1	NULL
(	NULL
ICAM-1	NULL
)	NULL
,	NULL
which	NULL
are	NULL
important	NULL
for	NULL
the	NULL
adhesion	NULL
of	NULL
cytotoxic	NULL
T	NULL
cells	NULL
.	NULL
``	NULL

Furthermore	NULL
,	NULL
certain	NULL
HLA	NULL
class	NULL
I	NULL
alleles	NULL
are	NULL
selectively	NULL
downregulated	NULL
in	NULL
BL	NULL
cells	NULL
.	NULL
``	NULL

Recent	NULL
research	NULL
points	NULL
to	NULL
the	NULL
restricted	NULL
expression	NULL
of	NULL
EBV	NULL
genes	NULL
as	NULL
the	NULL
main	NULL
reason	NULL
for	NULL
the	NULL
inability	NULL
of	NULL
the	NULL
immune	NULL
system	NULL
to	NULL
control	NULL
BL	NULL
cells	NULL
.	NULL
``	NULL

The	NULL
EBV-specific	NULL
cytotoxic	NULL
T	NULL
lymphocyte	NULL
(	NULL
CTL	NULL
)	NULL
response	NULL
seems	NULL
to	NULL
be	NULL
directed	NULL
mainly	NULL
against	NULL
epitopes	NULL
of	NULL
the	NULL
EBNA3	NULL
family	NULL
of	NULL
proteins	NULL
that	NULL
are	NULL
not	NULL
expressed	NULL
in	NULL
BL	NULL
,	NULL
while	NULL
CTLs	NULL
directed	NULL
against	NULL
the	NULL
EBNA1	NULL
protein	NULL
have	NULL
not	NULL
yet	NULL
been	NULL
observed	NULL
.	NULL
``	NULL

Previous	NULL
studies	NULL
of	NULL
EBV	NULL
gene	NULL
expression	NULL
in	NULL
BL	NULL
have	NULL
been	NULL
carried	NULL
out	NULL
using	NULL
mainly	NULL
cell	NULL
lines	NULL
and	NULL
employing	NULL
techniques	NULL
relying	NULL
on	NULL
the	NULL
extraction	NULL
of	NULL
proteins	NULL
or	NULL
RNA	NULL
from	NULL
cells	NULL
or	NULL
tissues	NULL
.	NULL
``	NULL

These	NULL
methods	NULL
are	NULL
of	NULL
limited	NULL
sensitivity	NULL
and	NULL
expression	NULL
of	NULL
viral	NULL
proteins	NULL
other	NULL
than	NULL
EBNA1	NULL
in	NULL
a	NULL
small	NULL
proportion	NULL
of	NULL
BL	NULL
cells	NULL
may	NULL
not	NULL
be	NULL
detected	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
have	NULL
used	NULL
sensitive	NULL
immunohistologic	NULL
techniques	NULL
to	NULL
re-ex-amine	NULL
EBV	NULL
gene	NULL
expression	NULL
in	NULL
BL	NULL
biopsy	NULL
specimens	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Tissues	NULL
.	NULL

Formalin-fixed	NULL
and	NULL
paraffin-embedded	NULL
biopsy	NULL
specimens	NULL
from	NULL
17	NULL
cases	NULL
were	NULL
included	NULL
in	NULL
this	NULL
study	NULL
.	NULL

All	NULL
cases	NULL
were	NULL
from	NULL
areas	NULL
in	NULL
Africa	NULL
where	NULL
Burkitt	NULL
's	NULL
lymphoma	NULL
is	NULL
endemic	NULL
(	NULL
8	NULL
from	NULL
Uganda	NULL
,	NULL
9	NULL
from	NULL
Malawi	NULL
)	NULL
and	NULL
collected	NULL
between	NULL
1972	NULL
and	NULL
1994	NULL
.	NULL

All	NULL
biopsy	NULL
specimens	NULL
were	NULL
from	NULL
children	NULL
,	NULL
aged	NULL
between	NULL
2	NULL
and	NULL
16	NULL
years	NULL
.	NULL

The	NULL
clinicopathologic	NULL
data	NULL
are	NULL
summarized	NULL
in	NULL
Table	NULL
1	NULL
.	NULL

All	NULL
cases	NULL
showed	NULL
histologic	NULL
features	NULL
characteristic	NULL
of	NULL
Burkitt	NULL
's	NULL
lymphoma	NULL
.	NULL

Im	NULL
From	NULL
the	NULL
Department	NULL
of	NULL
Pathology	NULL
and	NULL
Institute	NULL
for	NULL
Cancer	NULL
Stud-ies	NULL
,	NULL
University	NULL
of	NULL
Birmingham	NULL
,	NULL
Birmingham	NULL
,	NULL
UK	NULL
;	NULL
the	NULL
Department	NULL
of	NULL
Pathology	NULL
,	NULL
University	NULL
of	NULL
Southampton	NULL
,	NULL
Southampton	NULL
,	NULL
UK	NULL
;	NULL
the	NULL
Uganda	NULL
Virus	NULL
Research	NULL
Institute	NULL
,	NULL
Entebbe	NULL
,	NULL
Uganda	NULL
;	NULL
and	NULL
Kuluva	NULL
Hospital	NULL
,	NULL
Arua	NULL
,	NULL
Uganda	NULL
.	NULL

Submitted	NULL
November	NULL
30	NULL
,	NULL
1995	NULL
;	NULL
accepted	NULL
February	NULL
22	NULL
,	NULL
1995	NULL
.	NULL

Supported	NULL
by	NULL
the	NULL
Cancer	NULL
Research	NULL
Campaign	NULL
and	NULL
a	NULL
grant	NULL
from	NULL
the	NULL
United	NULL
Birmingham	NULL
Hospitals	NULL
Endowment	NULL
Fund	NULL
.	NULL

Address	NULL
reprint	NULL
requests	NULL
to	NULL
G.	NULL
Niedobitek	NULL
,	NULL
MD	NULL
,	NULL
Department	NULL
of	NULL
Pathology	NULL
,	NULL
University	NULL
of	NULL
Birmingham	NULL
,	NULL
Birmingham	NULL
B15	NULL
2TT	NULL
,	NULL
UK	NULL
.	NULL

The	NULL
publication	NULL
costs	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
page	NULL
charge	NULL
payment	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

©	NULL
1995	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
.	NULL

0006-497	NULL
659	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

660	NULL
Table	NULL
1	NULL
.	NULL

Expression	NULL
of	NULL
EBV	NULL
Gene	NULL
Products	NULL
in	NULL
Endemic	NULL
BL	NULL
Case	NULL
No	NULL
.	NULL

Age	NULL
tyriSex	NULL
Site	NULL
EBER	NULL
_	NULL
LMP1	NULL
EBNA-2	NULL
-	NULL
BZLF1	NULL
1	NULL
7/M	NULL
Mandible	NULL
+	NULL
-	NULL
-	NULL
2	NULL
7/F	NULL
Mandible	NULL
+	NULL
-	NULL
-	NULL
3	NULL
16/F	NULL
Ovary	NULL
+	NULL
-	NULL
+sc	NULL
+sC	NULL
4	NULL
10/F	NULL
Ovary	NULL
+	NULL
-	NULL
-	NULL
+sc	NULL
5	NULL
7/F	NULL
Lymph	NULL
node	NULL
+	NULL
-	NULL
+sC	NULL
6	NULL
9/M	NULL
Lymph	NULL
node	NULL
+	NULL
-	NULL
-	NULL
7	NULL
2/F	NULL
Ovary	NULL
+	NULL
+/-	NULL
-	NULL
+sc	NULL
8	NULL
14/M	NULL
Lymph	NULL
node	NULL
+	NULL
-	NULL
-	NULL
a	NULL
9	NULL
8/F	NULL
Ovary	NULL
+	NULL
-	NULL
-	NULL
10	NULL
2/M	NULL
Maxilla	NULL
+	NULL
-	NULL
-	NULL
+sC	NULL
11	NULL
5/M	NULL
Maxilla	NULL
+	NULL
-	NULL
-	NULL
+sC	NULL
12	NULL
6/M	NULL
Maxilla	NULL
+	NULL
-	NULL
-	NULL
13	NULL
5/M	NULL
Maxilla	NULL
+	NULL
-	NULL
-	NULL
14	NULL
12/F	NULL
Ovary	NULL
+	NULL
-	NULL
+sC	NULL
15	NULL
6/F	NULL
Ovary	NULL
+	NULL
-	NULL
-	NULL
16	NULL
11/M	NULL
Lymph	NULL
node	NULL
+	NULL
-	NULL
-	NULL
+sc	NULL
17	NULL
12/F	NULL
Mandible	NULL
+	NULL
+sc	NULL
-	NULL
Abbreviations	NULL
:	NULL
M	NULL
,	NULL
male	NULL
;	NULL
F	NULL
,	NULL
female	NULL
;	NULL
+	NULL
,	NULL
virtually	NULL
all	NULL
tumor	NULL
cells	NULL
positive	NULL
;	NULL
+/-	NULL
,	NULL
small	NULL
proportion	NULL
of	NULL
tumor	NULL
ceils	NULL
positive	NULL
;	NULL
+sc	NULL
,	NULL
isolated	NULL
scattered	NULL
tumor	NULL
cells	NULL
positive	NULL
;	NULL
-	NULL
,	NULL
negative	NULL
.	NULL

munostaining	NULL
with	NULL
the	NULL
CD20	NULL
monoclonal	NULL
antibody	NULL
(	NULL
MoAb	NULL
)	NULL
,	NULL
L26	NULL
,	NULL
confirmed	NULL
a	NULL
B-cell	NULL
phenotype	NULL
of	NULL
the	NULL
tumor	NULL
cells	NULL
in	NULL
all	NULL
cases	NULL
.	NULL

Staining	NULL
with	NULL
a	NULL
CD3-specific	NULL
rabbit	NULL
antiserum	NULL
(	NULL
Dako	NULL
,	NULL
High	NULL
Wycombe	NULL
,	NULL
UK	NULL
)	NULL
showed	NULL
the	NULL
presence	NULL
of	NULL
small	NULL
numbers	NULL
of	NULL
scattered	NULL
reactive	NULL
T	NULL
lymphocytes	NULL
admixed	NULL
with	NULL
the	NULL
tumor	NULL
cells	NULL
in	NULL
all	NULL
samples	NULL
.	NULL

Immunchistology	NULL
.	NULL

The	NULL
MoAb	NULL
,	NULL
Ber-H2	NULL
,	NULL
directed	NULL
against	NULL
the	NULL
CD30	NULL
lymphocyte	NULL
activation	NULL
antigen	NULL
and	NULL
the	NULL
be/2-specific	NULL
MoAb	NULL
,	NULL
124	NULL
,	NULL
were	NULL
obtained	NULL
from	NULL
Dako	NULL
.	NULL

For	NULL
the	NULL
detection	NULL
of	NULL
LMPI	NULL
,	NULL
the	NULL
MoAbs	NULL
CS1	NULL
,	NULL
CS2	NULL
,	NULL
CS3	NULL
,	NULL
and	NULL
CS4	NULL
were	NULL
used	NULL
either	NULL
alone	NULL
or	NULL
in	NULL
a	NULL
commercially	NULL
available	NULL
combination	NULL
(	NULL
Dako	NULL
)	NULL
.	NULL
``	NULL

In	NULL
addition	NULL
,	NULL
a	NULL
newly	NULL
produced	NULL
murine	NULL
IgGl	NULL
subclass	NULL
LMP	NULL
!	NULL

-specific	NULL
MoAb	NULL
,	NULL
LMPO24	NULL
,	NULL
was	NULL
used	NULL
.	NULL

This	NULL
antibody	NULL
was	NULL
generated	NULL
by	NULL
immunizing	NULL
balb/c	NULL
mice	NULL
with	NULL
purified	NULL
plasma	NULL
membranes	NULL
from	NULL
LMP	NULL
{	NULL
-expressing	NULL
insect	NULL
cells	NULL
that	NULL
were	NULL
infected	NULL
with	NULL
a	NULL
recombinant	NULL
LMP1	NULL
baculovirus	NULL
.	NULL

The	NULL
recombinant	NULL
baculovirus	NULL
was	NULL
a	NULL
kind	NULL
gift	NULL
of	NULL
Dr	NULL
F.	NULL
Grisser	NULL
(	NULL
Universitat-skliniken	NULL
des	NULL
Saarlandes	NULL
,	NULL
Homburg	NULL
,	NULL
Germany	NULL
)	NULL
and	NULL
has	NULL
been	NULL
described	NULL
previously	NULL
.	NULL
``	NULL

Spleen	NULL
cells	NULL
from	NULL
an	NULL
immunized	NULL
mouse	NULL
were	NULL
fused	NULL
with	NULL
the	NULL
nonsecreting	NULL
myeloma	NULL
fusion	NULL
partner	NULL
,	NULL
Sp2/0-Ag14	NULL
;	NULL
several	NULL
hybridomas	NULL
were	NULL
found	NULL
to	NULL
produce	NULL
antibodies	NULL
reactive	NULL
with	NULL
LMPI	NULL
in	NULL
fixed	NULL
cell	NULL
smears	NULL
and	NULL
in	NULL
Western	NULL
blotting	NULL
assays	NULL
.	NULL

The	NULL
LMPO24	NULL
clone	NULL
was	NULL
selected	NULL
for	NULL
use	NULL
in	NULL
this	NULL
study	NULL
because	NULL
of	NULL
its	NULL
strong	NULL
and	NULL
specific	NULL
reactivity	NULL
in	NULL
immunohistochemical	NULL
staining	NULL
of	NULL
paraffin-embedded	NULL
tissues	NULL
.	NULL

The	NULL
MoAb	NULL
,	NULL
PEZ	NULL
,	NULL
was	NULL
used	NULL
for	NULL
the	NULL
detection	NULL
of	NULL
the	NULL
EBNA2	NULL
protein	NULL
,	NULL
``	NULL
and	NULL
the	NULL
BZ1	NULL
MoAb	NULL
was	NULL
employed	NULL
for	NULL
the	NULL
detection	NULL
of	NULL
the	NULL
BZLE1	NULL
trans-activator	NULL
protein	NULL
.	NULL
``	NULL

''	NULL
All	NULL
MoAbs	NULL
were	NULL
applied	NULL
to	NULL
paraffin-sections	NULL
following	NULL
antigen	NULL
retrieval	NULL
as	NULL
described	NULL
.	NULL
``	NULL

In	NULL
brief	NULL
,	NULL
dewaxed	NULL
and	NULL
rehydrated	NULL
paraffin	NULL
sections	NULL
were	NULL
subjected	NULL
to	NULL
microwave	NULL
irradiation	NULL
in	NULL
1	NULL
dm	NULL
'	NULL
of	NULL
0.01	NULL
mol/L	NULL
citrate	NULL
buffer	NULL
for	NULL
40	NULL
minutes	NULL
at	NULL
750	NULL
W.	NULL
Sections	NULL
were	NULL
then	NULL
stained	NULL
using	NULL
the	NULL
alkaline	NULL
phosphatase	NULL
anti-alkaline	NULL
phosphatase	NULL
(	NULL
APAAP	NULL
)	NULL
method	NULL
as	NULL
described	NULL
.	NULL
``	NULL

In	NULL
situ	NULL
hybridization	NULL
.	NULL

-	NULL
The	NULL
plasmids	NULL
pBSJJJ1	NULL
and	NULL
pBSJJJ2	NULL
harboring	NULL
inserts	NULL
specific	NULL
for	NULL
EBER1	NULL
and	NULL
EBER2	NULL
,	NULL
respectively	NULL
,	NULL
and	NULL
the	NULL
plasmid	NULL
pBSW	NULL
containing	NULL
the	NULL
BamHI	NULL
W	NULL
fragment	NULL
of	NULL
the	NULL
EBV	NULL
genome	NULL
were	NULL
employed	NULL
in	NULL
this	NULL
study	NULL
.	NULL
``	NULL

Following	NULL
digestion	NULL
with	NULL
suitable	NULL
restriction	NULL
enzymes	NULL
,	NULL
single	NULL
stranded	NULL
RNA	NULL
probes	NULL
were	NULL
generated	NULL
from	NULL
these	NULL
plasmids	NULL
in	NULL
sense	NULL
and	NULL
antisense	NULL
direction	NULL
using	NULL
T3	NULL
and	NULL
T7	NULL
RNA	NULL
polymerases	NULL
(	NULL
Gibco-BRL	NULL
,	NULL
Paisley	NULL
,	NULL
UK	NULL
)	NULL
and	NULL
35S-dUTP	NULL
(	NULL
>	NULL
1000	NULL
Ci/mmol	NULL
,	NULL
Amersham	NULL
,	NULL
Little	NULL
Chalfont	NULL
,	NULL
UK	NULL
)	NULL
as	NULL
described	NULL
.	NULL

NIEDOBITEK	NULL
ET	NULL
AL	NULL
The	NULL
antisense	NULL
probes	NULL
derived	NULL
from	NULL
the	NULL
plasmids	NULL
pBSJJJ1	NULL
and	NULL
pBSJJJ2	NULL
were	NULL
mixed	NULL
to	NULL
increase	NULL
sensitivity	NULL
,	NULL
and	NULL
the	NULL
corresponding	NULL
sense	NULL
probes	NULL
were	NULL
also	NULL
mixed	NULL
.	NULL

In	NULL
situ	NULL
hybridization	NULL
was	NULL
performed	NULL
overnight	NULL
as	NULL
described	NULL
``	NULL
using	NULL
a	NULL
hybridization	NULL
mixture	NULL
containing	NULL
50	NULL
%	NULL
deionized	NULL
formamide	NULL
,	NULL
2	NULL
x	NULL
SSC	NULL
(	NULL
0.3	NULL
mol/L	NULL
NaCl	NULL
,	NULL
0.03	NULL
mol/L	NULL
sodium	NULL
citrate	NULL
,	NULL
pH	NULL
7.6	NULL
)	NULL
,	NULL
10	NULL
%	NULL
dextran	NULL
sulphate	NULL
,	NULL
10	NULL
mmol/L	NULL
dithio-threitol	NULL
(	NULL
DTT	NULL
)	NULL
,	NULL
0.2	NULL
mg/mL	NULL
yeast	NULL
tRNA	NULL
,	NULL
and	NULL
10°	NULL
cpm	NULL
of	NULL
labeled	NULL
probe	NULL
per	NULL
slide	NULL
.	NULL

After	NULL
hybridization	NULL
,	NULL
slides	NULL
were	NULL
washed	NULL
for	NULL
at	NULL
least	NULL
4	NULL
hours	NULL
in	NULL
50	NULL
%	NULL
deionized	NULL
formamide	NULL
,	NULL
1	NULL
x	NULL
SSC	NULL
,	NULL
10	NULL
mmol/L	NULL
DTT	NULL
at	NULL
52°C	NULL
,	NULL
rinsed	NULL
in	NULL
0.1	NULL
x	NULL
SSC	NULL
,	NULL
and	NULL
dipped	NULL
in	NULL
a	NULL
1:2	NULL
dilution	NULL
of	NULL
fiford	NULL
GS	NULL
emulsion	NULL
.	NULL

Slides	NULL
were	NULL
exposed	NULL
at	NULL
4°C	NULL
for	NULL
3	NULL
to	NULL
10	NULL
days	NULL
,	NULL
developed	NULL
,	NULL
fixed	NULL
,	NULL
and	NULL
counterstained	NULL
.	NULL

Controls	NULL
.	NULL

-	NULL
Paraffin	NULL
sections	NULL
of	NULL
a	NULL
tonsil	NULL
from	NULL
a	NULL
patient	NULL
with	NULL
acute	NULL
infectious	NULL
mononucleosis	NULL
(	NULL
IM	NULL
)	NULL
were	NULL
used	NULL
as	NULL
positive	NULL
control	NULL
in	NULL
all	NULL
experiments	NULL
.	NULL

EBER	NULL
in	NULL
situ	NULL
hybridization	NULL
showed	NULL
numerous	NULL
EBV-infected	NULL
lymphoid	NULL
blasts	NULL
in	NULL
extrafollicular	NULL
areas	NULL
as	NULL
described	NULL
previously	NULL
.	NULL
``	NULL

A	NULL
large	NULL
number	NULL
of	NULL
cells	NULL
expressing	NULL
mRNA	NULL
derived	NULL
from	NULL
the	NULL
BamHI	NULL
W	NULL
fragment	NULL
of	NULL
the	NULL
EBV	NULL
genome	NULL
was	NULL
also	NULL
seen	NULL
in	NULL
the	NULL
same	NULL
areas	NULL
.	NULL

Immunohistology	NULL
with	NULL
the	NULL
CS1-4	NULL
mixture	NULL
of	NULL
MoAbs	NULL
and	NULL
with	NULL
the	NULL
MoAb	NULL
,	NULL
LMPO24	NULL
,	NULL
showed	NULL
many	NULL
LMP	NULL
I-positive	NULL
large	NULL
lymphoid	NULL
blasts	NULL
.	NULL

Similarly	NULL
,	NULL
many	NULL
cells	NULL
showing	NULL
an	NULL
EBNA2-specific	NULL
staining	NULL
were	NULL
seen	NULL
with	NULL
the	NULL
MoAb	NULL
,	NULL
PEZ	NULL
.	NULL

Staining	NULL
with	NULL
the	NULL
BZI	NULL
MoAb	NULL
showed	NULL
scattered	NULL
smaller	NULL
lymphoid	NULL
cells	NULL
expressing	NULL
the	NULL
BZLFI1	NULL
protein	NULL
of	NULL
EBV	NULL
.	NULL

Preliminary	NULL
experiments	NULL
with	NULL
the	NULL
CSI	NULL
,	NULL
CS2	NULL
,	NULL
CS3	NULL
,	NULL
and	NULL
CS4	NULL
MoAbs	NULL
on	NULL
sections	NULL
from	NULL
an	NULL
IM	NULL
tonsil	NULL
showed	NULL
large	NULL
numbers	NULL
of	NULL
LMPL	NULL
expressing	NULL
lymphoid	NULL
blasts	NULL
with	NULL
each	NULL
individual	NULL
MoAb	NULL
as	NULL
seen	NULL
with	NULL
the	NULL
CS1-4	NULL
mixture	NULL
.	NULL

However	NULL
,	NULL
the	NULL
CS3	NULL
and	NULL
particularly	NULL
the	NULL
CS4	NULL
MoAbs	NULL
produced	NULL
a	NULL
strong	NULL
staining	NULL
of	NULL
many	NULL
nuclei	NULL
and	NULL
a	NULL
cytoplasmic	NULL
labeling	NULL
of	NULL
endothelial	NULL
cells	NULL
in	NULL
addition	NULL
to	NULL
the	NULL
specific	NULL
staining	NULL
.	NULL

This	NULL
has	NULL
been	NULL
occasionally	NULL
observed	NULL
previously	NULL
with	NULL
the	NULL
CS1-4	NULL
mixture	NULL
.	NULL
``	NULL

Serial	NULL
dilution	NULL
of	NULL
the	NULL
CS3	NULL
and	NULL
CS4	NULL
MoAbs	NULL
showed	NULL
that	NULL
at	NULL
tissue	NULL
culture	NULL
supernatant	NULL
dilutions	NULL
of	NULL
about	NULL
1:500	NULL
,	NULL
the	NULL
nuclear	NULL
staining	NULL
had	NULL
disappeared	NULL
almost	NULL
completely	NULL
,	NULL
while	NULL
the	NULL
specific	NULL
staining	NULL
of	NULL
EBV-infected	NULL
lymphoid	NULL
blasts	NULL
was	NULL
still	NULL
clearly	NULL
visible	NULL
.	NULL

A	NULL
weak	NULL
staining	NULL
of	NULL
endothelial	NULL
cells	NULL
remained	NULL
,	NULL
but	NULL
this	NULL
did	NULL
not	NULL
interfere	NULL
with	NULL
the	NULL
interpretation	NULL
of	NULL
results	NULL
.	NULL

The	NULL
CS1	NULL
,	NULL
CS2	NULL
,	NULL
and	NULL
LMPO24	NULL
MoAbs	NULL
did	NULL
not	NULL
show	NULL
any	NULL
background	NULL
staining	NULL
at	NULL
dilutions	NULL
of	NULL
1:50	NULL
.	NULL

RESULTS	NULL
EBV	NULL
status	NULL
of	NULL
tumors	NULL
.	NULL

In	NULL
situ	NULL
hybridization	NULL
with	NULL
the	NULL
EBER1-	NULL
and	NULL
EBER2-specific	NULL
probes	NULL
showed	NULL
the	NULL
presence	NULL
of	NULL
EBV	NULL
in	NULL
virtually	NULL
all	NULL
tumor	NULL
cells	NULL
of	NULL
all	NULL
17	NULL
BL	NULL
cases	NULL
(	NULL
Fig	NULL
1	NULL
and	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

LMP	NULL
!	NULL

expression	NULL
.	NULL

Immunohistology	NULL
with	NULL
the	NULL
CS1-4	NULL
mixture	NULL
of	NULL
MoAbs	NULL
showed	NULL
labeling	NULL
of	NULL
a	NULL
substantial	NULL
number	NULL
of	NULL
tumor	NULL
cells	NULL
in	NULL
one	NULL
case	NULL
(	NULL
Fig	NULL
2A	NULL
and	NULL
case	NULL
no	NULL
.	NULL

7	NULL
in	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

Positive	NULL
cells	NULL
tended	NULL
to	NULL
show	NULL
focal	NULL
aggregation	NULL
.	NULL

Because	NULL
of	NULL
the	NULL
focal	NULL
distribution	NULL
of	NULL
these	NULL
cells	NULL
the	NULL
proportion	NULL
of	NULL
labeled	NULL
tumor	NULL
cells	NULL
was	NULL
difficult	NULL
to	NULL
assess	NULL
.	NULL

While	NULL
in	NULL
some	NULL
areas	NULL
up	NULL
to	NULL
40	NULL
CS1-4~positive	NULL
cells	NULL
were	NULL
found	NULL
per	NULL
high	NULL
power	NULL
field	NULL
(	NULL
Fig	NULL
2A	NULL
)	NULL
,	NULL
the	NULL
vast	NULL
majority	NULL
of	NULL
tumor	NULL
cells	NULL
was	NULL
unlabeled	NULL
.	NULL

The	NULL
proportion	NULL
of	NULL
CS1-4-positive	NULL
cells	NULL
was	NULL
estimated	NULL
to	NULL
be	NULL
less	NULL
than	NULL
1	NULL
%	NULL
of	NULL
the	NULL
total	NULL
tumor	NULL
cell	NULL
population	NULL
.	NULL

Another	NULL
case	NULL
(	NULL
case	NULL
17	NULL
in	NULL
Table	NULL
1	NULL
)	NULL
,	NULL
displayed	NULL
very	NULL
few	NULL
cells	NULL
labeled	NULL
with	NULL
the	NULL
CS1-4	NULL
MoAbs	NULL
,	NULL
again	NULL
representing	NULL
well	NULL
under	NULL
1	NULL
%	NULL
of	NULL
all	NULL
tumor	NULL
cells	NULL
.	NULL

To	NULL
assess	NULL
the	NULL
specificity	NULL
of	NULL
this	NULL
staining	NULL
result	NULL
,	NULL
the	NULL
CS1	NULL
,	NULL
CS2	NULL
,	NULL
CS3	NULL
,	NULL
CS4	NULL
,	NULL
and	NULL
LMPO24	NULL
MoAbs	NULL
were	NULL
applied	NULL
separately	NULL
to	NULL
these	NULL
cases	NULL
.	NULL

All	NULL
five	NULL
antibodies	NULL
showed	NULL
the	NULL
same	NULL
staining	NULL
pattern	NULL
in	NULL
both	NULL
cases	NULL
confirming	NULL
the	NULL
specificity	NULL
of	NULL
the	NULL
staining	NULL
result	NULL
(	NULL
Fig	NULL
2B	NULL
)	NULL
.	NULL

While	NULL
the	NULL
majority	NULL
of	NULL
LMP	NULL
1-expressing	NULL
cells	NULL
shared	NULL
the	NULL
morphologic	NULL
features	NULL
of	NULL
BL	NULL
tu-	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

EBV	NULL
GENE	NULL
EXPRESSION	NULL
IN	NULL
BURKITT	NULL
'S	NULL
LYMPHOMA	NULL
Fig	NULL
1	NULL
.	NULL

In	NULL
situ	NULL
hybridization	NULL
with	NULL
radiolabeled	NULL
EBER-specific	NULL
probes	NULL
shows	NULL
accumulation	NULL
of	NULL
silver	NULL
grains	NULL
over	NULL
virtually	NULL
all	NULL
tumor	NULL
cell	NULL
nuclei	NULL
of	NULL
this	NULL
Burkitt	NULL
's	NULL
lymphoma	NULL
,	NULL
indicating	NULL
the	NULL
presence	NULL
of	NULL
Epstein-Barr	NULL
virus	NULL
.	NULL

mor	NULL
cells	NULL
,	NULL
some	NULL
cells	NULL
had	NULL
enlarged	NULL
nuclei	NULL
with	NULL
prominent	NULL
nucleoli	NULL
.	NULL

EBNA2	NULL
expression	NULL
.	NULL

-	NULL
Immunohistology	NULL
with	NULL
the	NULL
EBNA2	NULL
specific	NULL
MoAb	NULL
,	NULL
PE2	NULL
,	NULL
resulted	NULL
in	NULL
nuclear	NULL
staining	NULL
of	NULL
some	NULL
oie	NULL
r	NULL
*	NULL
@	NULL
w	NULL
-~	NULL
<	NULL
$	NULL
#	NULL
s	NULL
,	NULL
he	NULL
a	NULL
45	NULL
``	NULL
wad	NULL
419	NULL
T	NULL
ithin	NULL
*	NULL
``	NULL
waa	NULL
``	NULL
Fig	NULL
2	NULL
.	NULL

Immunohistology	NULL
shows	NULL
expression	NULL
of	NULL
LMP1	NULL
in	NULL
some	NULL
tumor	NULL
cells	NULL
of	NULL
a	NULL
Burkitt	NULL
's	NULL
lymphoma	NULL
(	NULL
case	NULL
no	NULL
.	NULL

7	NULL
)	NULL
using	NULL
MoAbs	NULL
CS1-4	NULL
(	NULL
A	NULL
)	NULL
and	NULL
CS3	NULL
(	NULL
B	NULL
)	NULL
and	NULL
the	NULL
APAAP	NULL
technique	NULL
.	NULL

661	NULL
tumor	NULL
cells	NULL
in	NULL
three	NULL
cases	NULL
(	NULL
Fig	NULL
3A	NULL
and	NULL
B	NULL
and	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

The	NULL
largest	NULL
number	NULL
of	NULL
EBNAZ-positive	NULL
cells	NULL
was	NULL
observed	NULL
in	NULL
case	NULL
no	NULL
.	NULL

3	NULL
.	NULL

In	NULL
this	NULL
case	NULL
,	NULL
labeled	NULL
cells	NULL
showed	NULL
a	NULL
focal	NULL
distribution	NULL
pattern	NULL
and	NULL
staining	NULL
was	NULL
often	NULL
weak	NULL
,	NULL
making	NULL
assessment	NULL
of	NULL
the	NULL
number	NULL
of	NULL
EBNA2Z-expressing	NULL
cells	NULL
difficult	NULL
.	NULL

However	NULL
,	NULL
the	NULL
vast	NULL
majority	NULL
of	NULL
tumor	NULL
cells	NULL
did	NULL
not	NULL
show	NULL
EBNA2-specific	NULL
staining	NULL
and	NULL
thus	NULL
the	NULL
overall	NULL
proportion	NULL
of	NULL
stained	NULL
cells	NULL
was	NULL
small	NULL
(	NULL
<	NULL
1	NULL
%	NULL
)	NULL
.	NULL

Only	NULL
very	NULL
few	NULL
scattered	NULL
cells	NULL
labeled	NULL
with	NULL
the	NULL
PE2	NULL
mAB	NULL
were	NULL
seen	NULL
in	NULL
the	NULL
other	NULL
2	NULL
cases	NULL
.	NULL

Notably	NULL
,	NULL
these	NULL
3	NULL
cases	NULL
did	NULL
not	NULL
show	NULL
any	NULL
LMP	NULL
cells	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

Most	NULL
PE2-positive	NULL
cells	NULL
shared	NULL
the	NULL
morphology	NULL
of	NULL
tumor	NULL
cells	NULL
,	NULL
but	NULL
a	NULL
few	NULL
isolated	NULL
cells	NULL
with	NULL
a	NULL
more	NULL
immu-noblast-like	NULL
appearance	NULL
were	NULL
noticed	NULL
in	NULL
1	NULL
case	NULL
.	NULL

To	NULL
ascertain	NULL
the	NULL
specificity	NULL
of	NULL
this	NULL
staining	NULL
,	NULL
in	NULL
situ	NULL
hybridization	NULL
with	NULL
RNA	NULL
probes	NULL
derived	NULL
from	NULL
the	NULL
plasmid	NULL
pBSW	NULL
was	NULL
performed	NULL
on	NULL
these	NULL
3	NULL
cases	NULL
.	NULL

This	NULL
probe	NULL
detects	NULL
mRNA	NULL
transcripts	NULL
derived	NULL
from	NULL
the	NULL
BamHI	NULL
W	NULL
fragment	NULL
of	NULL
the	NULL
viral	NULL
genome	NULL
,	NULL
which	NULL
are	NULL
transcribed	NULL
in	NULL
type	NULL
III	NULL
latency	NULL
,	NULL
and	NULL
are	NULL
part	NULL
of	NULL
the	NULL
primary	NULL
transcript	NULL
encoding	NULL
for	NULL
EBNA2	NULL
,	NULL
as	NULL
well	NULL
as	NULL
the	NULL
other	NULL
EBNAs	NULL
.	NULL

Scattered	NULL
cells	NULL
expressing	NULL
this	NULL
RNA	NULL
were	NULL
detected	NULL
in	NULL
one	NULL
of	NULL
the	NULL
three	NULL
cases	NULL
with	NULL
PE2-positive	NULL
cells	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

BZLFI	NULL
expression	NULL
.	NULL

Using	NULL
the	NULL
BZLFI-specific	NULL
MoAb	NULL
,	NULL
BZ1	NULL
,	NULL
nuclear	NULL
staining	NULL
of	NULL
isolated	NULL
tumor	NULL
cells	NULL
was	NULL
observed	NULL
in	NULL
6	NULL
BL	NULL
cases	NULL
(	NULL
Fig	NULL
4	NULL
and	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

Invariably	NULL
,	NULL
these	NULL
cells	NULL
showed	NULL
the	NULL
morphologic	NULL
features	NULL
of	NULL
BL	NULL
tumor	NULL
cells	NULL
(	NULL
Fig	NULL
4	NULL
)	NULL
.	NULL

CD30	NULL
and	NULL
bel2	NULL
expression	NULL
.	NULL

Staining	NULL
with	NULL
the	NULL
MoAb	NULL
Ber-H2	NULL
of	NULL
16	NULL
cases	NULL
showed	NULL
a	NULL
few	NULL
CD30-positive	NULL
lymphoid	NULL
cells	NULL
in	NULL
1	NULL
case	NULL
(	NULL
case	NULL
no	NULL
.	NULL

5	NULL
in	NULL
Table	NULL
1	NULL
)	NULL
,	NULL
and	NULL
this	NULL
case	NULL
also	NULL
displayed	NULL
some	NULL
EBNA2Z-positive	NULL
tumor	NULL
cells	NULL
.	NULL

However	NULL
,	NULL
the	NULL
CD30-expressing	NULL
cells	NULL
had	NULL
the	NULL
morphologic	NULL
features	NULL
of	NULL
lymphoid	NULL
blasts	NULL
and	NULL
were	NULL
located	NULL
at	NULL
the	NULL
edge	NULL
of	NULL
the	NULL
tumor	NULL
and	NULL
thus	NULL
probably	NULL
represented	NULL
reactive	NULL
lymphoid	NULL
cells	NULL
rather	NULL
than	NULL
transformed	NULL
tumor	NULL
cells	NULL
.	NULL

The	NULL
5	NULL
cases	NULL
containing	NULL
LMP1	NULL
or	NULL
EBNA2	NULL
expressing	NULL
cells	NULL
were	NULL
stained	NULL
with	NULL
a	NULL
be/2-specific	NULL
MoAb	NULL
,	NULL
124	NULL
.	NULL

In	NULL
all	NULL
5	NULL
cases	NULL
,	NULL
be/2	NULL
expression	NULL
was	NULL
restricted	NULL
to	NULL
small	NULL
lymphoid	NULL
cells	NULL
.	NULL

No	NULL
be/2	NULL
expression	NULL
in	NULL
tumor	NULL
cells	NULL
was	NULL
observed	NULL
.	NULL

From	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

662	NULL
NIEDOBITEK	NULL
ET	NULL
AL	NULL
Fig	NULL
3	NULL
.	NULL

Immunchistology	NULL
with	NULL
the	NULL
MoAb	NULL
PE2	NULL
shows	NULL
expression	NULL
of	NULL
EBNA2	NULL
in	NULL
isolated	NULL
tumor	NULL
cells	NULL
{	NULL
arrows	NULL
)	NULL
of	NULL
Burkitt	NULL
's	NULL
lymphoma	NULL
case	NULL
no	NULL
.	NULL

5	NULL
(	NULL
A	NULL
)	NULL
and	NULL
case	NULL
no	NULL
.	NULL

3	NULL
(	NULL
B	NULL
)	NULL
using	NULL
the	NULL
APAAP	NULL
technique	NULL
.	NULL

Fig	NULL
4	NULL
.	NULL

A	NULL
single	NULL
tumor	NULL
cell	NULL
is	NULL
seen	NULL
expressing	NULL
the	NULL
BZLF1	NULL
protein	NULL
of	NULL
EBV	NULL
as	NULL
detected	NULL
by	NULL
APAAP	NULL
immu-nohistochemistry	NULL
with	NULL
the	NULL
MoAb	NULL
BZ1	NULL
(	NULL
case	NULL
no	NULL
.	NULL

16	NULL
)	NULL
.	NULL

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

EBV	NULL
GENE	NULL
EXPRESSION	NULL
IN	NULL
BURKITT	NULL
'S	NULL
LYMPHOMA	NULL
DISCUSSION	NULL
In	NULL
this	NULL
study	NULL
of	NULL
17	NULL
EBV-positive	NULL
endemic	NULL
BL	NULL
cases	NULL
,	NULL
variable	NULL
but	NULL
small	NULL
numbers	NULL
of	NULL
LMP1-expressing	NULL
cells	NULL
were	NULL
observed	NULL
in	NULL
2	NULL
cases	NULL
and	NULL
isolated	NULL
EBNA2-positive	NULL
tumor	NULL
cells	NULL
were	NULL
detectable	NULL
in	NULL
3	NULL
other	NULL
cases	NULL
.	NULL

In	NULL
the	NULL
remaining	NULL
12	NULL
cases	NULL
,	NULL
EBV	NULL
latent	NULL
gene	NULL
expression	NULL
was	NULL
restricted	NULL
to	NULL
the	NULL
EBERs	NULL
,	NULL
consistent	NULL
with	NULL
a	NULL
tight	NULL
type	NULL
I	NULL
latency	NULL
.	NULL

A	NULL
few	NULL
isolated	NULL
BL	NULL
cells	NULL
expressing	NULL
the	NULL
BZLFI1	NULL
trans-activator	NULL
protein	NULL
of	NULL
EBV	NULL
were	NULL
observed	NULL
in	NULL
6	NULL
cases	NULL
.	NULL

This	NULL
protein	NULL
induces	NULL
the	NULL
switch	NULL
from	NULL
latent	NULL
to	NULL
replicative	NULL
EBV	NULL
infection	NULL
.	NULL

Thus	NULL
,	NULL
expression	NULL
of	NULL
the	NULL
BZLF1	NULL
protein	NULL
suggests	NULL
that	NULL
a	NULL
small	NULL
minority	NULL
of	NULL
BL	NULL
cells	NULL
in	NULL
some	NULL
cases	NULL
may	NULL
enter	NULL
into	NULL
the	NULL
lytic	NULL
cycle	NULL
.	NULL

This	NULL
is	NULL
in	NULL
keeping	NULL
with	NULL
the	NULL
occurrence	NULL
of	NULL
occasional	NULL
virus-producing	NULL
cells	NULL
in	NULL
some	NULL
BL	NULL
cell	NULL
lines	NULL
``	NULL
and	NULL
with	NULL
the	NULL
recent	NULL
demonstration	NULL
using	NULL
Southern	NULL
blot	NULL
hybridization	NULL
of	NULL
replicating	NULL
EBV	NULL
DNA	NULL
in	NULL
some	NULL
BL	NULL
biopsy	NULL
specimens	NULL
.	NULL
``	NULL

The	NULL
detection	NULL
of	NULL
some	NULL
EBNA2Z-	NULL
and	NULL
LMP	NULL
cells	NULL
in	NULL
a	NULL
proportion	NULL
of	NULL
endemic	NULL
BL	NULL
cases	NULL
was	NULL
unexpected	NULL
in	NULL
the	NULL
light	NULL
of	NULL
previous	NULL
studies	NULL
consistently	NULL
demonstrating	NULL
a	NULL
type	NULL
1	NULL
latency	NULL
in	NULL
BL	NULL
.	NULL
``	NULL

However	NULL
,	NULL
these	NULL
studies	NULL
have	NULL
employed	NULL
methods	NULL
based	NULL
on	NULL
the	NULL
extraction	NULL
of	NULL
proteins	NULL
and	NULL
nucleic	NULL
acids	NULL
,	NULL
such	NULL
as	NULL
Western	NULL
or	NULL
Northern	NULL
blotting	NULL
.	NULL

While	NULL
these	NULL
techniques	NULL
allow	NULL
the	NULL
analysis	NULL
of	NULL
EBV	NULL
gene	NULL
expression	NULL
in	NULL
the	NULL
majority	NULL
cell	NULL
population	NULL
,	NULL
they	NULL
may	NULL
not	NULL
be	NULL
sufficiently	NULL
sensitive	NULL
to	NULL
detect	NULL
different	NULL
expression	NULL
patterns	NULL
in	NULL
small	NULL
fractions	NULL
of	NULL
the	NULL
total	NULL
cell	NULL
population	NULL
.	NULL

Also	NULL
,	NULL
these	NULL
studies	NULL
have	NULL
examined	NULL
mainly	NULL
early	NULL
passage	NULL
BL	NULL
cell	NULL
lines	NULL
and	NULL
thus	NULL
the	NULL
number	NULL
of	NULL
BL	NULL
biopsy	NULL
specimens	NULL
analyzed	NULL
for	NULL
EBV	NULL
gene	NULL
expression	NULL
reported	NULL
in	NULL
the	NULL
literature	NULL
is	NULL
very	NULL
small	NULL
.	NULL

Several	NULL
control	NULL
experiments	NULL
were	NULL
performed	NULL
to	NULL
assess	NULL
the	NULL
specificity	NULL
of	NULL
our	NULL
immunostaining	NULL
results	NULL
.	NULL

The	NULL
2	NULL
cases	NULL
with	NULL
LMP	NULL
cells	NULL
as	NULL
detected	NULL
using	NULL
the	NULL
CS1-4	NULL
mixture	NULL
of	NULL
MoAbs	NULL
were	NULL
examined	NULL
using	NULL
these	NULL
four	NULL
MoAbs	NULL
separately	NULL
and	NULL
also	NULL
with	NULL
a	NULL
newly	NULL
generated	NULL
LMPI-specific	NULL
MoAb	NULL
,	NULL
LMPO24	NULL
.	NULL

Identical	NULL
staining	NULL
patterns	NULL
were	NULL
obtained	NULL
in	NULL
both	NULL
cases	NULL
with	NULL
all	NULL
five	NULL
MoAbs	NULL
.	NULL

In	NULL
1	NULL
of	NULL
the	NULL
3	NULL
cases	NULL
displaying	NULL
scattered	NULL
cells	NULL
labeled	NULL
with	NULL
the	NULL
EBNAZ-specific	NULL
MoAb	NULL
,	NULL
small	NULL
numbers	NULL
expressing	NULL
RNAs	NULL
derived	NULL
from	NULL
the	NULL
BamHI	NULL
W	NULL
fragment	NULL
of	NULL
the	NULL
EBV	NULL
genome	NULL
were	NULL
identified	NULL
.	NULL

These	NULL
transcripts	NULL
are	NULL
part	NULL
of	NULL
the	NULL
EBNA2	NULL
mRNA	NULL
expressed	NULL
in	NULL
Lat	NULL
III	NULL
.	NULL

*	NULL
Thus	NULL
,	NULL
these	NULL
control	NULL
experiments	NULL
provide	NULL
additional	NULL
evidence	NULL
for	NULL
the	NULL
specificity	NULL
of	NULL
our	NULL
immunostaining	NULL
results	NULL
.	NULL

Expression	NULL
of	NULL
LMP1	NULL
may	NULL
occur	NULL
during	NULL
lytic	NULL
infection	NULL
in	NULL
B	NULL
cells	NULL
.	NULL
``	NULL

However	NULL
,	NULL
in	NULL
our	NULL
cases	NULL
,	NULL
there	NULL
was	NULL
no	NULL
correlation	NULL
between	NULL
LMP1	NULL
and	NULL
BZLF1	NULL
expression	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

A	NULL
few	NULL
BZLF1-positive	NULL
BL	NULL
cells	NULL
were	NULL
seen	NULL
in	NULL
the	NULL
case	NULL
showing	NULL
the	NULL
most	NULL
LMP1-positive	NULL
cells	NULL
(	NULL
case	NULL
no	NULL
.	NULL

7	NULL
,	NULL
Table	NULL
1	NULL
)	NULL
,	NULL
but	NULL
these	NULL
were	NULL
infrequent	NULL
in	NULL
comparison	NULL
to	NULL
the	NULL
LMP1-positive	NULL
cells	NULL
and	NULL
they	NULL
also	NULL
showed	NULL
a	NULL
different	NULL
pattern	NULL
of	NULL
distribution	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
presence	NULL
of	NULL
LMP1l-positive	NULL
cells	NULL
in	NULL
these	NULL
two	NULL
biopsy	NULL
specimens	NULL
clearly	NULL
reflects	NULL
the	NULL
expression	NULL
of	NULL
LMP1	NULL
in	NULL
the	NULL
context	NULL
of	NULL
latent	NULL
infection	NULL
.	NULL

The	NULL
expression	NULL
of	NULL
LMP	NULL
has	NULL
been	NULL
demonstrated	NULL
previously	NULL
in	NULL
3	NULL
of	NULL
11	NULL
EBV-positive	NULL
acquired	NULL
immunodeficiency	NULL
syndrome	NULL
(	NULL
AIDS	NULL
)	NULL
related	NULL
BL	NULL
cases	NULL
.	NULL
``	NULL

''	NULL
Thus	NULL
,	NULL
the	NULL
detection	NULL
of	NULL
LMP	NULL
cells	NULL
in	NULL
our	NULL
cases	NULL
no	NULL
.	NULL

7	NULL
and	NULL
17	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
raises	NULL
the	NULL
question	NULL
as	NULL
to	NULL
the	NULL
possibility	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
(	NULL
HIV	NULL
)	NULL
infection	NULL
in	NULL
these	NULL
patients	NULL
.	NULL

However	NULL
,	NULL
the	NULL
biopsy	NULL
663	NULL
specimen	NULL
from	NULL
case	NULL
no	NULL
.	NULL

7	NULL
was	NULL
obtained	NULL
in	NULL
1982	NULL
before	NULL
the	NULL
outbreak	NULL
of	NULL
the	NULL
AIDS	NULL
epidemic	NULL
.	NULL

This	NULL
tumor	NULL
had	NULL
developed	NULL
in	NULL
an	NULL
ovary	NULL
of	NULL
a	NULL
young	NULL
girl	NULL
.	NULL

In	NULL
case	NULL
no	NULL
.	NULL

17	NULL
,	NULL
the	NULL
tumor	NULL
had	NULL
developed	NULL
in	NULL
the	NULL
mandible	NULL
of	NULL
a	NULL
12-year	NULL
old	NULL
girl	NULL
in	NULL
1994	NULL
.	NULL

Therefore	NULL
,	NULL
both	NULL
cases	NULL
would	NULL
seem	NULL
to	NULL
represent	NULL
typical	NULL
examples	NULL
of	NULL
endemic	NULL
BL	NULL
.	NULL

A	NULL
recent	NULL
autopsy	NULL
study	NULL
from	NULL
Cote	NULL
d'Ivoire	NULL
has	NULL
also	NULL
concluded	NULL
that	NULL
BL	NULL
is	NULL
not	NULL
a	NULL
common	NULL
AIDS-associated	NULL
complication	NULL
in	NULL
Africa	NULL
,	NULL
particularly	NULL
in	NULL
children	NULL
.	NULL
``	NULL

Thus	NULL
,	NULL
while	NULL
we	NULL
can	NULL
not	NULL
definitely	NULL
rule	NULL
out	NULL
this	NULL
possibility	NULL
,	NULL
it	NULL
seems	NULL
very	NULL
unlikely	NULL
that	NULL
these	NULL
cases	NULL
represent	NULL
AIDS-related	NULL
lymphomas	NULL
.	NULL

In	NULL
12	NULL
of	NULL
our	NULL
endemic	NULL
BL	NULL
cases	NULL
,	NULL
the	NULL
immunohistologic	NULL
results	NULL
were	NULL
in	NULL
keeping	NULL
with	NULL
a	NULL
tight	NULL
Lat	NULL
I	NULL
form	NULL
of	NULL
EBV	NULL
infection	NULL
as	NULL
described	NULL
in	NULL
previous	NULL
studies	NULL
.	NULL
``	NULL

''	NULL
The	NULL
detection	NULL
of	NULL
EBNAZ	NULL
and	NULL
LMP	NULL
1	NULL
in	NULL
some	NULL
tumor	NULL
cells	NULL
of	NULL
5	NULL
cases	NULL
demonstrates	NULL
that	NULL
forms	NULL
of	NULL
virus	NULL
latency	NULL
other	NULL
than	NULL
Lat	NULL
I	NULL
may	NULL
be	NULL
realized	NULL
in	NULL
endemic	NULL
BL	NULL
.	NULL

It	NULL
is	NULL
interesting	NULL
to	NULL
note	NULL
in	NULL
this	NULL
context	NULL
that	NULL
LMP1-positive	NULL
cells	NULL
were	NULL
not	NULL
detected	NULL
in	NULL
those	NULL
cases	NULL
showing	NULL
EBNAZ-expressing	NULL
cells	NULL
.	NULL

Thus	NULL
,	NULL
it	NULL
appears	NULL
that	NULL
in	NULL
some	NULL
BL	NULL
cases	NULL
,	NULL
a	NULL
proportion	NULL
of	NULL
tumor	NULL
cells	NULL
may	NULL
display	NULL
a	NULL
Lat	NULL
II	NULL
that	NULL
is	NULL
characterized	NULL
by	NULL
the	NULL
expression	NULL
of	NULL
EBNA1	NULL
and	NULL
the	NULL
LMPs	NULL
only	NULL
.	NULL

A	NULL
similar	NULL
phenotype	NULL
has	NULL
been	NULL
demonstrated	NULL
by	NULL
Hamilton-Dutoit	NULL
et	NULL
al	NULL
``	NULL
``	NULL
in	NULL
3	NULL
of	NULL
11	NULL
EBV-positive	NULL
AIDS-related	NULL
Burkitt-type	NULL
lymphomas	NULL
.	NULL

The	NULL
expression	NULL
of	NULL
EBNA2	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
LMP	NULL
1	NULL
is	NULL
more	NULL
unusual	NULL
,	NULL
as	NULL
EBNAZ	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
induce	NULL
LMP	NULL
1	NULL
expression	NULL
in	NULL
B	NULL
cells	NULL
.	NULL
``	NULL

However	NULL
,	NULL
this	NULL
phenotype	NULL
has	NULL
been	NULL
observed	NULL
previously	NULL
in	NULL
some	NULL
posttransplant	NULL
lymphomas	NULL
.	NULL
``	NULL

Moreover	NULL
,	NULL
this	NULL
form	NULL
of	NULL
latency	NULL
is	NULL
clearly	NULL
realized	NULL
in	NULL
a	NULL
proportion	NULL
of	NULL
cells	NULL
in	NULL
PTLDs	NULL
and	NULL
AIDS-related	NULL
lymphomas	NULL
with	NULL
Lat	NULL
III	NULL
where	NULL
the	NULL
number	NULL
of	NULL
EBNA2Z-positive	NULL
cells	NULL
may	NULL
be	NULL
much	NULL
greater	NULL
than	NULL
that	NULL
of	NULL
LMP1-positive	NULL
cells	NULL
``	NULL
*	NULL
(	NULL
unpublished	NULL
observation	NULL
)	NULL
.	NULL

It	NULL
has	NULL
to	NULL
be	NULL
emphasized	NULL
,	NULL
however	NULL
,	NULL
that	NULL
even	NULL
in	NULL
those	NULL
5	NULL
cases	NULL
with	NULL
LMP1-	NULL
or	NULL
EBNA2-positive	NULL
cells	NULL
,	NULL
the	NULL
vast	NULL
majority	NULL
of	NULL
tumor	NULL
cells	NULL
exhibited	NULL
a	NULL
phenotype	NULL
consistent	NULL
with	NULL
Lat	NULL
L.	NULL
In	NULL
vitro	NULL
,	NULL
some	NULL
BL	NULL
cell	NULL
lines	NULL
show	NULL
a	NULL
spontaneous	NULL
phenotypic	NULL
drift	NULL
from	NULL
Lat	NULL
I	NULL
to	NULL
Lat	NULL
III	NULL
.	NULL
``	NULL

''	NULL
Thus	NULL
,	NULL
the	NULL
detection	NULL
of	NULL
LMP1	NULL
or	NULL
EBNA2	NULL
in	NULL
BL	NULL
cells	NULL
suggests	NULL
that	NULL
such	NULL
a	NULL
drift	NULL
may	NULL
also	NULL
occur	NULL
in	NULL
vivo	NULL
.	NULL

Alternatively	NULL
,	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
the	NULL
BL	NULL
cells	NULL
expressing	NULL
LMP1	NULL
or	NULL
EBNAZ	NULL
represent	NULL
earlier	NULL
stages	NULL
in	NULL
tumor	NULL
development	NULL
before	NULL
the	NULL
establishment	NULL
of	NULL
a	NULL
tight	NULL
Lat	NULL
I	NULL
.	NULL

While	NULL
the	NULL
first	NULL
possibility	NULL
appears	NULL
more	NULL
likely	NULL
,	NULL
it	NULL
is	NULL
,	NULL
at	NULL
present	NULL
,	NULL
not	NULL
possible	NULL
to	NULL
clarify	NULL
this	NULL
issue	NULL
with	NULL
certainty	NULL
.	NULL

A	NULL
step	NULL
in	NULL
this	NULL
direction	NULL
would	NULL
be	NULL
a	NULL
more	NULL
detailed	NULL
phenotypic	NULL
characterization	NULL
of	NULL
BL	NULL
cells	NULL
expressing	NULL
EBNA2	NULL
or	NULL
LMPI1	NULL
to	NULL
see	NULL
if	NULL
the	NULL
phenotypic	NULL
changes	NULL
associated	NULL
with	NULL
the	NULL
drift	NULL
from	NULL
Lat	NULL
I	NULL
to	NULL
Lat	NULL
III	NULL
in	NULL
vitro	NULL
are	NULL
reflected	NULL
in	NULL
these	NULL
tumor	NULL
cells	NULL
in	NULL
vivo	NULL
.	NULL

Our	NULL
preliminary	NULL
analysis	NULL
suggests	NULL
that	NULL
CD30	NULL
,	NULL
which	NULL
is	NULL
expressed	NULL
in	NULL
type	NULL
III	NULL
but	NULL
not	NULL
in	NULL
type	NULL
I	NULL
BL	NULL
cell	NULL
lines	NULL
,	NULL
``	NULL
is	NULL
not	NULL
upregulated	NULL
in	NULL
EBNAZ	NULL
or	NULL
LMP1	NULL
expressing	NULL
BL	NULL
cells	NULL
in	NULL
vivo	NULL
.	NULL

Similarly	NULL
,	NULL
expression	NULL
of	NULL
the	NULL
be/2	NULL
oncoprotein	NULL
was	NULL
not	NULL
observed	NULL
in	NULL
these	NULL
BL	NULL
cases	NULL
.	NULL

This	NULL
is	NULL
surprising	NULL
in	NULL
view	NULL
of	NULL
the	NULL
recently	NULL
demonstrated	NULL
ability	NULL
of	NULL
LMP1	NULL
to	NULL
upregulate	NULL
bel2	NULL
expression	NULL
in	NULL
BL	NULL
cell	NULL
lines	NULL
.	NULL
``	NULL

However	NULL
,	NULL
a	NULL
few	NULL
EBNA2Z-	NULL
or	NULL
LMP1-expressing	NULL
cells	NULL
were	NULL
noticed	NULL
that	NULL
displayed	NULL
an	NULL
immu-noblast-like	NULL
morphology	NULL
,	NULL
and	NULL
this	NULL
problem	NULL
will	NULL
have	NULL
to	NULL
be	NULL
addressed	NULL
in	NULL
more	NULL
detail	NULL
using	NULL
frozen	NULL
biopsies	NULL
that	NULL
will	NULL
allow	NULL
a	NULL
broader	NULL
range	NULL
of	NULL
antigens	NULL
to	NULL
be	NULL
analyzed	NULL
.	NULL

The	NULL
phenotypic	NULL
analysis	NULL
of	NULL
LMP1	NULL
or	NULL
EBNA2	NULL
expressing	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

664	NULL
BL	NULL
cells	NULL
is	NULL
also	NULL
important	NULL
with	NULL
respect	NULL
to	NULL
the	NULL
understanding	NULL
of	NULL
the	NULL
immunologic	NULL
control	NULL
of	NULL
BL	NULL
in	NULL
vivo	NULL
.	NULL

EBV-positive	NULL
endemic	NULL
BL	NULL
develops	NULL
in	NULL
the	NULL
face	NULL
of	NULL
an	NULL
EBV-specific	NULL
immunity	NULL
apparently	NULL
sufficient	NULL
to	NULL
prevent	NULL
the	NULL
outgrowth	NULL
of	NULL
conventional	NULL
EBV	NULL
transformed	NULL
B	NULL
cells	NULL
,	NULL
ie	NULL
,	NULL
immunoblastic	NULL
lymphomas	NULL
with	NULL
a	NULL
type	NULL
III	NULL
latency	NULL
.	NULL

This	NULL
raises	NULL
the	NULL
question	NULL
as	NULL
to	NULL
which	NULL
mechanisms	NULL
are	NULL
responsible	NULL
for	NULL
allowing	NULL
BL	NULL
cells	NULL
to	NULL
evade	NULL
EBV	NULL
-specific	NULL
CTL	NULL
surveillance	NULL
.	NULL

Previous	NULL
studies	NULL
have	NULL
variably	NULL
implicated	NULL
the	NULL
characteristically	NULL
low	NULL
expression	NULL
of	NULL
adhesion	NULL
molecules	NULL
in	NULL
BL	NULL
,	NULL
the	NULL
downregulation	NULL
of	NULL
HLA	NULL
class	NULL
I	NULL
expression	NULL
,	NULL
or	NULL
the	NULL
absence	NULL
of	NULL
those	NULL
EBV	NULL
proteins	NULL
that	NULL
provide	NULL
the	NULL
immunogenic	NULL
target	NULL
epitopes	NULL
,	NULL
eg	NULL
,	NULL
EBNA3B	NULL
and	NULL
EBNA3C	NULL
.	NULL

``	NULL
``	NULL
~	NULL
``	NULL
Recent	NULL
evidence	NULL
seems	NULL
to	NULL
suggest	NULL
that	NULL
the	NULL
most	NULL
important	NULL
factor	NULL
is	NULL
the	NULL
restriction	NULL
of	NULL
EBV	NULL
protein	NULL
expression	NULL
to	NULL
EBNA1	NULL
,	NULL
which	NULL
is	NULL
the	NULL
only	NULL
EBV-encoded	NULL
protein	NULL
against	NULL
which	NULL
T-cell	NULL
immunity	NULL
has	NULL
,	NULL
as	NULL
yet	NULL
,	NULL
not	NULL
been	NULL
demonstrated	NULL
.	NULL
``	NULL

Thus	NULL
,	NULL
the	NULL
absence	NULL
of	NULL
BL	NULL
cells	NULL
displaying	NULL
a	NULL
type	NULL
II	NULL
or	NULL
type	NULL
III	NULL
EBV	NULL
latency	NULL
from	NULL
most	NULL
BL	NULL
biopsies	NULL
and	NULL
the	NULL
scarcity	NULL
of	NULL
such	NULL
cells	NULL
in	NULL
those	NULL
cases	NULL
where	NULL
they	NULL
are	NULL
detectable	NULL
could	NULL
be	NULL
explained	NULL
by	NULL
the	NULL
rapid	NULL
elimination	NULL
of	NULL
these	NULL
cells	NULL
by	NULL
EBV-specific	NULL
CTLs	NULL
.	NULL

This	NULL
could	NULL
also	NULL
explain	NULL
that	NULL
in	NULL
those	NULL
cases	NULL
showing	NULL
EBNA2Z-positive	NULL
cells	NULL
,	NULL
LMP1	NULL
expression	NULL
was	NULL
not	NULL
observed	NULL
.	NULL

During	NULL
the	NULL
switch	NULL
from	NULL
Lat	NULL
I	NULL
to	NULL
Lat	NULL
III	NULL
,	NULL
EBNAZ	NULL
expression	NULL
precedes	NULL
LMP1	NULL
expres-sion	NULL
.	NULL
``	NULL

Thus	NULL
,	NULL
it	NULL
seems	NULL
possible	NULL
that	NULL
EBNA2-expressing	NULL
BL	NULL
cells	NULL
are	NULL
eliminated	NULL
by	NULL
CTLs	NULL
before	NULL
the	NULL
EBNA2-induced	NULL
upregulation	NULL
of	NULL
LMP	NULL
1	NULL
expression	NULL
can	NULL
occur	NULL
.	NULL

If	NULL
the	NULL
relatively	NULL
small	NULL
number	NULL
of	NULL
T	NULL
cells	NULL
detected	NULL
in	NULL
BL	NULL
biopsies	NULL
is	NULL
sufficient	NULL
to	NULL
mediate	NULL
such	NULL
an	NULL
effect	NULL
remains	NULL
to	NULL
be	NULL
established	NULL
.	NULL

In	NULL
sum-mary	NULL
,	NULL
this	NULL
is	NULL
the	NULL
first	NULL
demonstration	NULL
of	NULL
EBV	NULL
latent	NULL
proteins	NULL
other	NULL
than	NULL
EBNA1	NULL
in	NULL
tumor	NULL
cells	NULL
of	NULL
endemic	NULL
BL	NULL
.	NULL

The	NULL
expression	NULL
of	NULL
EBNAZ	NULL
in	NULL
some	NULL
tumor	NULL
cells	NULL
suggests	NULL
a	NULL
drift	NULL
towards	NULL
Lat	NULL
IH	NULL
,	NULL
as	NULL
seen	NULL
in	NULL
some	NULL
BL	NULL
cell	NULL
lines	NULL
in	NULL
vitro	NULL
.	NULL

In	NULL
other	NULL
cases	NULL
,	NULL
expression	NULL
of	NULL
LMP1	NULL
has	NULL
been	NULL
observed	NULL
without	NULL
detectable	NULL
EBNAZ	NULL
expression	NULL
,	NULL
raising	NULL
the	NULL
possibility	NULL
that	NULL
BL	NULL
cells	NULL
may	NULL
,	NULL
under	NULL
certain	NULL
conditions	NULL
,	NULL
sustain	NULL
Lat	NULL
II	NULL
.	NULL

These	NULL
possibilities	NULL
will	NULL
have	NULL
to	NULL
be	NULL
addressed	NULL
at	NULL
the	NULL
transcriptional	NULL
level	NULL
in	NULL
future	NULL
studies	NULL
.	NULL

Our	NULL
observations	NULL
demonstrate	NULL
that	NULL
in	NULL
virus-associated	NULL
human	NULL
tumors	NULL
,	NULL
individual	NULL
tumor	NULL
cells	NULL
may	NULL
sustain	NULL
a	NULL
form	NULL
of	NULL
EBV	NULL
latency	NULL
that	NULL
is	NULL
different	NULL
from	NULL
the	NULL
pattern	NULL
prevailing	NULL
in	NULL
the	NULL
majority	NULL
cell	NULL
population	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
operational	NULL
definition	NULL
of	NULL
different	NULL
forms	NULL
of	NULL
EBV	NULL
latency	NULL
is	NULL
not	NULL
easily	NULL
applicable	NULL
to	NULL
human	NULL
tumors	NULL
in	NULL
vivo	NULL
.	NULL

ACKNOWLEDGMENT	NULL
We	NULL
are	NULL
grateful	NULL
to	NULL
Drs	NULL
M.	NULL
Hutt	NULL
,	NULL
C.	NULL
Fletcher	NULL
,	NULL
R.G	NULL
.	NULL

Downing	NULL
,	NULL
and	NULL
D.	NULL
Morton	NULL
for	NULL
providing	NULL
Burkitt	NULL
lymphoma	NULL
biopsies	NULL
and	NULL
to	NULL
Clair	NULL
Glendining	NULL
for	NULL
expert	NULL
photographic	NULL
assistance	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Zur	NULL
Hausen	NULL
H	NULL
,	NULL
Schulte-Holthausen	NULL
H	NULL
,	NULL
Klein	NULL
G	NULL
,	NULL
Henle	NULL
W	NULL
,	NULL
Henle	NULL
G	NULL
,	NULL
Clifford	NULL
P	NULL
,	NULL
Santesson	NULL
L	NULL
:	NULL
EBV	NULL
DNA	NULL
in	NULL
biopsies	NULL
of	NULL
Burkitt	NULL
tumours	NULL
and	NULL
anaplastic	NULL
carcinomas	NULL
of	NULL
the	NULL
nasopharynx	NULL
.	NULL

Nature	NULL
228:1056	NULL
,	NULL
1970	NULL
2	NULL
.	NULL

Miller	NULL
G	NULL
:	NULL
Epstein-Barr	NULL
Virus-Biology	NULL
,	NULL
Pathogenesis	NULL
,	NULL
and	NULL
Medical	NULL
Aspects	NULL
,	NULL
in	NULL
Fields	NULL
BN	NULL
,	NULL
Knipe	NULL
DM	NULL
(	NULL
eds	NULL
)	NULL
:	NULL
Virology	NULL
.	NULL

New	NULL
York	NULL
,	NULL
NY	NULL
,	NULL
Raven	NULL
,	NULL
1990	NULL
,	NULL
p	NULL
1921	NULL
3	NULL
.	NULL

Herbst	NULL
H	NULL
,	NULL
Stein	NULL
H	NULL
,	NULL
Niedobitek	NULL
G	NULL
:	NULL
Epstein-Barr	NULL
virus	NULL
and	NULL
CD30+	NULL
malignant	NULL
lymphomas	NULL
.	NULL

CRC	NULL
Crit	NULL
Rev	NULL
Oncog	NULL
4:191	NULL
,	NULL
1993	NULL
4	NULL
.	NULL

Swerdlow	NULL
SH	NULL
:	NULL
Post-transplant	NULL
lymphoproliferative	NULL
disorders	NULL
:	NULL
NIEDOBITEK	NULL
ET	NULL
AL	NULL
A	NULL
morphologic	NULL
,	NULL
phenotypic	NULL
and	NULL
genotypic	NULL
spectrum	NULL
of	NULL
disease	NULL
.	NULL

His-topathology	NULL
20:373	NULL
,	NULL
1992	NULL
5	NULL
.	NULL

Craig	NULL
FE	NULL
,	NULL
Gulley	NULL
ML	NULL
,	NULL
Banks	NULL
PM	NULL
:	NULL
Posttransplantation	NULL
lymphoproliferative	NULL
disorders	NULL
.	NULL

Am	NULL
J	NULL
Clin	NULL
Pathol	NULL
99:265	NULL
,	NULL
1993	NULL
6	NULL
.	NULL

Wolf	NULL
H	NULL
,	NULL
zur	NULL
Hausen	NULL
H	NULL
,	NULL
Becker	NULL
V	NULL
:	NULL
;	NULL
EB	NULL
viral	NULL
genomes	NULL
in	NULL
epithelial	NULL
nasopharyngeal	NULL
carcinoma	NULL
cells	NULL
.	NULL

Nature	NULL
244:245	NULL
,	NULL
1973	NULL
7	NULL
.	NULL

Niedobitek	NULL
G	NULL
:	NULL
Patterns	NULL
of	NULL
Epstein-Barr	NULL
virus	NULL
infection	NULL
in	NULL
non-Hodgkin	NULL
lymphomas	NULL
.	NULL

J	NULL
Pathol	NULL
175:259	NULL
,	NULL
1995	NULL
(	NULL
editorial	NULL
)	NULL
8	NULL
.	NULL

Raab-Traub	NULL
N	NULL
,	NULL
Flynn	NULL
K	NULL
:	NULL
The	NULL
structure	NULL
of	NULL
the	NULL
termini	NULL
of	NULL
the	NULL
Epstein-Barr	NULL
virus	NULL
as	NULL
a	NULL
marker	NULL
of	NULL
clonal	NULL
cellular	NULL
proliferation	NULL
.	NULL

Cell	NULL
47:883	NULL
,	NULL
1986	NULL
9	NULL
.	NULL

Kieff	NULL
E	NULL
,	NULL
Liebowitz	NULL
D	NULL
:	NULL
Epstein-Barr	NULL
virus	NULL
and	NULL
its	NULL
replication	NULL
,	NULL
in	NULL
Fields	NULL
BN	NULL
,	NULL
Knipe	NULL
DM	NULL
(	NULL
eds	NULL
)	NULL
:	NULL
Virology	NULL
.	NULL

New	NULL
York	NULL
,	NULL
NY	NULL
,	NULL
Raven	NULL
,	NULL
1990	NULL
,	NULL
p	NULL
1889	NULL
10	NULL
.	NULL

Howe	NULL
JG	NULL
,	NULL
Steitz	NULL
JA	NULL
:	NULL
Localization	NULL
of	NULL
Epstein-Barr	NULL
virus-encoded	NULL
small	NULL
RNAs	NULL
by	NULL
in	NULL
situ	NULL
hybridization	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
83:9006	NULL
,	NULL
1986	NULL
11	NULL
.	NULL

Young	NULL
L	NULL
,	NULL
Alfieri	NULL
C	NULL
,	NULL
Hennessy	NULL
K	NULL
,	NULL
Evans	NULL
H	NULL
,	NULL
O'Hara	NULL
C	NULL
,	NULL
Anderson	NULL
KC	NULL
,	NULL
Ritz	NULL
J	NULL
,	NULL
Shapiro	NULL
RS	NULL
,	NULL
Rickinson	NULL
A	NULL
,	NULL
Kieff	NULL
E	NULL
,	NULL
Cohen	NULL
JI	NULL
:	NULL
Expression	NULL
of	NULL
Epstein-Barr	NULL
virus	NULL
transformation-associated	NULL
genes	NULL
in	NULL
tissues	NULL
of	NULL
patients	NULL
with	NULL
EBV	NULL
lymphoproliferative	NULL
disease	NULL
.	NULL

N	NULL
Engl	NULL
J	NULL
Med	NULL
321:1080	NULL
,	NULL
1989	NULL
12	NULL
.	NULL

Thomas	NULL
JA	NULL
,	NULL
Hotchin	NULL
NA	NULL
,	NULL
Allday	NULL
MJ	NULL
,	NULL
Amlot	NULL
P	NULL
,	NULL
Rose	NULL
M	NULL
,	NULL
Yacoub	NULL
M	NULL
,	NULL
Crawford	NULL
DH	NULL
:	NULL
Immunohistology	NULL
of	NULL
Epstein-Barr	NULL
virus-associated	NULL
antigens	NULL
in	NULL
B	NULL
cell	NULL
disorders	NULL
from	NULL
immunocompromised	NULL
individuals	NULL
.	NULL

Transplantation	NULL
49:944	NULL
,	NULL
1990	NULL
13	NULL
.	NULL

Herbst	NULL
H	NULL
,	NULL
Dallenbach	NULL
F	NULL
,	NULL
Hummel	NULL
M	NULL
,	NULL
Niedobitek	NULL
G	NULL
,	NULL
Pileri	NULL
S	NULL
,	NULL
Miiller-Lantzsch	NULL
N	NULL
,	NULL
Stein	NULL
H	NULL
:	NULL
Epstein-Barr	NULL
virus	NULL
latent	NULL
membrane	NULL
protein	NULL
expression	NULL
in	NULL
Hodgkin-	NULL
and	NULL
Reed-Stemberg	NULL
cells	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
88:4766	NULL
,	NULL
1991	NULL
14	NULL
.	NULL

Deacon	NULL
EM	NULL
,	NULL
Pallesen	NULL
G	NULL
,	NULL
Niedobitek	NULL
G	NULL
,	NULL
Crocker	NULL
J	NULL
,	NULL
Brooks	NULL
L	NULL
,	NULL
Rickinson	NULL
AB	NULL
,	NULL
Young	NULL
LS	NULL
:	NULL
Epstein-Barr	NULL
virus	NULL
and	NULL
Hodgkin	NULL
's	NULL
disease	NULL
:	NULL
Transcriptional	NULL
analysis	NULL
of	NULL
virus	NULL
latency	NULL
in	NULL
the	NULL
malignant	NULL
cells	NULL
.	NULL

J	NULL
Exp	NULL
Med	NULL
177:339	NULL
,	NULL
1993	NULL
15	NULL
.	NULL

Young	NULL
LS	NULL
,	NULL
Dawson	NULL
CW	NULL
,	NULL
Clark	NULL
D	NULL
,	NULL
Rupani	NULL
H	NULL
,	NULL
Busson	NULL
P	NULL
,	NULL
Tursz	NULL
T	NULL
,	NULL
Johnson	NULL
A	NULL
,	NULL
Rickinson	NULL
AB	NULL
:	NULL
Epstein-Barr	NULL
virus	NULL
gene	NULL
expression	NULL
in	NULL
nasopharyngeal	NULL
carcinoma	NULL
.	NULL

J	NULL
Gen	NULL
Virol	NULL
69:1051	NULL
,	NULL
1988	NULL
16	NULL
.	NULL

Fahraeus	NULL
R	NULL
,	NULL
Fu	NULL
HL	NULL
,	NULL
Emmberg	NULL
I	NULL
,	NULL
Finke	NULL
J	NULL
,	NULL
Rowe	NULL
M	NULL
,	NULL
Klein	NULL
G	NULL
,	NULL
Falk	NULL
K	NULL
,	NULL
Nilsson	NULL
E	NULL
,	NULL
Yadav	NULL
M	NULL
,	NULL
Busson	NULL
P	NULL
,	NULL
Tursz	NULL
T	NULL
,	NULL
Kallin	NULL
B	NULL
:	NULL
Expression	NULL
of	NULL
Epstein-Barr	NULL
virus-encoded	NULL
proteins	NULL
in	NULL
nasopharyngeal	NULL
carcinoma	NULL
.	NULL

Int	NULL
J	NULL
Cancer	NULL
42:329	NULL
,	NULL
1988	NULL
17	NULL
.	NULL

Rowe	NULL
M	NULL
,	NULL
Rowe	NULL
DT	NULL
,	NULL
Gregory	NULL
CD	NULL
,	NULL
Young	NULL
LS	NULL
,	NULL
Farrell	NULL
PJ	NULL
,	NULL
Rupani	NULL
H	NULL
,	NULL
Rickinson	NULL
AB	NULL
:	NULL
Differences	NULL
in	NULL
B	NULL
cell	NULL
growth	NULL
phenotype	NULL
reflect	NULL
novel	NULL
patterns	NULL
of	NULL
Epstein-Barr	NULL
virus	NULL
latent	NULL
gene	NULL
expression	NULL
in	NULL
Burkitt	NULL
's	NULL
lymphoma	NULL
cells	NULL
.	NULL

EMBO	NULL
J	NULL
6:2743	NULL
,	NULL
1987	NULL
18	NULL
.	NULL

Rowe	NULL
DT	NULL
,	NULL
Rowe	NULL
M	NULL
,	NULL
Evan	NULL
GI	NULL
,	NULL
Wallace	NULL
LE	NULL
,	NULL
Farrell	NULL
PJ	NULL
,	NULL
Rickinson	NULL
AB	NULL
:	NULL
Restricted	NULL
expression	NULL
of	NULL
EBV	NULL
latent	NULL
genes	NULL
and	NULL
T-lympho-cyte-detected	NULL
membrane	NULL
antigen	NULL
in	NULL
Burkitt	NULL
's	NULL
lymphoma	NULL
cells	NULL
.	NULL

EMBO	NULL
J	NULL
5:2599	NULL
,	NULL
1986	NULL
19	NULL
.	NULL

Gregory	NULL
CD	NULL
,	NULL
Rowe	NULL
M	NULL
,	NULL
Rickinson	NULL
AB	NULL
:	NULL
Different	NULL
Epstein-Barr	NULL
virus	NULL
(	NULL
EBV	NULL
)	NULL
-B	NULL
cell	NULL
interactions	NULL
in	NULL
phenotypically	NULL
distinct	NULL
clones	NULL
of	NULL
a	NULL
Burkitt	NULL
lymphoma	NULL
cell	NULL
line	NULL
.	NULL

J	NULL
Gen	NULL
Virol	NULL
71:1481	NULL
,	NULL
1990	NULL
20	NULL
.	NULL

Sample	NULL
J	NULL
,	NULL
Brooks	NULL
L	NULL
,	NULL
Sample	NULL
C	NULL
,	NULL
Young	NULL
LS	NULL
,	NULL
Rowe	NULL
M	NULL
,	NULL
Rickinson	NULL
A	NULL
,	NULL
Kieff	NULL
E	NULL
:	NULL
Restricted	NULL
Epstein-Barr	NULL
virus	NULL
protein	NULL
expression	NULL
in	NULL
Burkitt	NULL
lymphoma	NULL
is	NULL
reflected	NULL
in	NULL
a	NULL
novel	NULL
EBNA-1	NULL
mRNA	NULL
and	NULL
transcriptional	NULL
initiation	NULL
site	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
88:6343	NULL
,	NULL
1991	NULL
21	NULL
.	NULL

Gregory	NULL
CD	NULL
,	NULL
Murray	NULL
RJ	NULL
,	NULL
Edwards	NULL
CF	NULL
,	NULL
Rickinson	NULL
AB	NULL
:	NULL
Downregulation	NULL
of	NULL
cell	NULL
adhesion	NULL
molecules	NULL
LFA-3	NULL
and	NULL
ICAM-1	NULL
in	NULL
Epstein-Barr	NULL
virus-positive	NULL
Burkitt	NULL
's	NULL
lymphoma	NULL
underlies	NULL
tumor	NULL
cell	NULL
escape	NULL
from	NULL
virus-specific	NULL
T	NULL
cell	NULL
surveillance	NULL
.	NULL

J	NULL
Exp	NULL
Med	NULL
167:1811	NULL
,	NULL
1988	NULL
22	NULL
.	NULL

Masucci	NULL
MG	NULL
,	NULL
Zhang	NULL
QJ	NULL
,	NULL
Gavioli	NULL
R	NULL
,	NULL
De	NULL
Campos-Lima	NULL
PO	NULL
,	NULL
Murray	NULL
RJ	NULL
,	NULL
Brooks	NULL
J	NULL
,	NULL
Griffin	NULL
H	NULL
,	NULL
Ploégh	NULL
H	NULL
,	NULL
Rickinson	NULL
AB	NULL
:	NULL
Immune	NULL
escape	NULL
by	NULL
Epstein-Barr	NULL
virus	NULL
(	NULL
EBV	NULL
)	NULL
carrying	NULL
Burkitt	NULL
's	NULL
lymphoma	NULL
:	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

EBV	NULL
GENE	NULL
EXPRESSION	NULL
IN	NULL
BURKITT	NULL
'S	NULL
LYMPHOMA	NULL
in	NULL
vitro	NULL
reconstitution	NULL
of	NULL
sensitivity	NULL
to	NULL
EBV-specific	NULL
cytotoxic	NULL
T	NULL
cells	NULL
.	NULL

Int	NULL
Immunol	NULL
4:1283	NULL
,	NULL
1992	NULL
23	NULL
.	NULL

Gavioli	NULL
R	NULL
,	NULL
De	NULL
Campos-Lima	NULL
PO	NULL
,	NULL
Kurilla	NULL
MG	NULL
,	NULL
Kieff	NULL
E	NULL
,	NULL
Klein	NULL
G	NULL
,	NULL
Masucci	NULL
MG	NULL
:	NULL
Recognition	NULL
of	NULL
the	NULL
Epstein-Barr	NULL
virus-encoded	NULL
nuclear	NULL
antigens	NULL
EBNA-4	NULL
and	NULL
EBNA-6	NULL
by	NULL
HLA-A1l-restricted	NULL
cytotoxic	NULL
T	NULL
lymphocytes	NULL
:	NULL
Implications	NULL
for	NULL
down-regulation	NULL
of	NULL
HLA-All	NULL
in	NULL
Burkitt	NULL
lymphoma	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
89:5862	NULL
,	NULL
1992	NULL
24	NULL
.	NULL

Griffin	NULL
H	NULL
,	NULL
Rowe	NULL
M	NULL
,	NULL
Murray	NULL
R	NULL
,	NULL
Brooks	NULL
J	NULL
,	NULL
Rickinson	NULL
A	NULL
:	NULL
Restoration	NULL
of	NULL
the	NULL
LFA-3	NULL
adhesion	NULL
pathway	NULL
in	NULL
Burkitt	NULL
's	NULL
lymphoma	NULL
cells	NULL
using	NULL
an	NULL
LFA-3	NULL
recombinant	NULL
vaccinia	NULL
virus	NULL
:	NULL
consequences	NULL
for	NULL
T	NULL
cell	NULL
recognition	NULL
.	NULL

Eur	NULL
J	NULL
Immunol	NULL
22	NULL
;	NULL
:1741	NULL
,	NULL
1992	NULL
25	NULL
.	NULL

Khanna	NULL
R	NULL
,	NULL
Burrows	NULL
SR	NULL
,	NULL
Subrbier	NULL
A	NULL
,	NULL
Jacob	NULL
CA	NULL
,	NULL
Griffin	NULL
H	NULL
,	NULL
Misko	NULL
IS	NULL
,	NULL
Sculley	NULL
TB	NULL
,	NULL
Rowe	NULL
M	NULL
,	NULL
Rickinson	NULL
AB	NULL
,	NULL
Moss	NULL
DJ	NULL
:	NULL
EBV	NULL
peptide	NULL
epitope	NULL
sensitization	NULL
restores	NULL
human	NULL
cytotoxic	NULL
T	NULL
cell	NULL
recognition	NULL
of	NULL
Burkitt	NULL
's	NULL
lymphoma	NULL
cells	NULL
.	NULL

Evidence	NULL
for	NULL
a	NULL
critical	NULL
role	NULL
for	NULL
ICAM-2	NULL
.	NULL

J	NULL
Immunol	NULL
150:5154	NULL
,	NULL
1993	NULL
26	NULL
.	NULL

Khanna	NULL
R	NULL
,	NULL
Burrows	NULL
SR	NULL
,	NULL
Kurilia	NULL
MG	NULL
,	NULL
Jacob	NULL
CA	NULL
,	NULL
Misko	NULL
IS	NULL
,	NULL
Sculley	NULL
TB	NULL
,	NULL
Kieff	NULL
E	NULL
,	NULL
Moss	NULL
DJ	NULL
:	NULL
Localization	NULL
of	NULL
Epstein-Barr	NULL
virus	NULL
cytotoxic	NULL
T	NULL
cell	NULL
epitopes	NULL
using	NULL
recombinant	NULL
vaccinia	NULL
:	NULL
Implications	NULL
for	NULL
vaccine	NULL
development	NULL
.	NULL

J	NULL
Exp	NULL
Med	NULL
176:169	NULL
,	NULL
1992	NULL
27	NULL
.	NULL

Murray	NULL
RJ	NULL
,	NULL
Kurilla	NULL
MG	NULL
,	NULL
Brooks	NULL
JM	NULL
,	NULL
Thomas	NULL
WA	NULL
,	NULL
Rowe	NULL
M	NULL
,	NULL
Kieff	NULL
E	NULL
,	NULL
Rickinson	NULL
AB	NULL
:	NULL
Identification	NULL
of	NULL
target	NULL
antigens	NULL
for	NULL
the	NULL
human	NULL
cytotoxic	NULL
T	NULL
cell	NULL
response	NULL
to	NULL
Epstein-Barr	NULL
virus	NULL
(	NULL
EBV	NULL
)	NULL
:	NULL
Implications	NULL
for	NULL
the	NULL
immune	NULL
control	NULL
of	NULL
EBV-positive	NULL
malignancies	NULL
.	NULL

J	NULL
Exp	NULL
Med	NULL
176:157	NULL
,	NULL
1992	NULL
28	NULL
.	NULL

Rowe	NULL
M	NULL
,	NULL
Evans	NULL
HS	NULL
,	NULL
Young	NULL
LS	NULL
,	NULL
Hennessy	NULL
K	NULL
,	NULL
Kieff	NULL
E	NULL
,	NULL
Rickinson	NULL
AB	NULL
:	NULL
Monocional	NULL
antibodies	NULL
to	NULL
the	NULL
latent	NULL
membrane	NULL
protein	NULL
of	NULL
Epstein-Barr	NULL
virus	NULL
reveal	NULL
heterogeneity	NULL
of	NULL
the	NULL
protein	NULL
and	NULL
inducible	NULL
expression	NULL
in	NULL
virus-transformed	NULL
cells	NULL
.	NULL

J	NULL
Gen	NULL
Virol	NULL
68:1575	NULL
,	NULL
1987	NULL
29	NULL
.	NULL

Chen	NULL
HF	NULL
,	NULL
Kevanjah	NULL
S	NULL
,	NULL
Suentzenich	NULL
KO	NULL
,	NULL
Grisser	NULL
FA	NULL
,	NULL
Miller-Lantzsch	NULL
N	NULL
:	NULL
Expression	NULL
of	NULL
the	NULL
Epstein-Barr	NULL
virus	NULL
latent	NULL
membrane	NULL
protein	NULL
(	NULL
LMP	NULL
)	NULL
in	NULL
insect	NULL
cells	NULL
and	NULL
detection	NULL
of	NULL
antibodies	NULL
in	NULL
human	NULL
sera	NULL
against	NULL
this	NULL
protein	NULL
.	NULL

Virology	NULL
190:106	NULL
,	NULL
1992	NULL
30	NULL
.	NULL

Young	NULL
LS	NULL
,	NULL
Lau	NULL
R	NULL
,	NULL
Rowe	NULL
M	NULL
,	NULL
Niedobitek	NULL
G	NULL
,	NULL
Packham	NULL
G	NULL
,	NULL
Sha-nahan	NULL
F	NULL
,	NULL
Rowe	NULL
DT	NULL
,	NULL
Greenspan	NULL
D	NULL
,	NULL
Greenspan	NULL
JS	NULL
,	NULL
Rickinson	NULL
AB	NULL
,	NULL
Farrell	NULL
PJ	NULL
:	NULL
Differentiation-associated	NULL
expression	NULL
of	NULL
the	NULL
Epstein-Barr	NULL
665	NULL
virus	NULL
BZLFI	NULL
transactivator	NULL
protein	NULL
in	NULL
oral	NULL
hairy	NULL
leukoplakia	NULL
.	NULL

J	NULL
Virol	NULL
65:2868	NULL
,	NULL
1991	NULL
31	NULL
.	NULL

Niedobitek	NULL
G	NULL
,	NULL
Agathanggelou	NULL
A	NULL
,	NULL
Finerty	NULL
S	NULL
,	NULL
Tierney	NULL
R	NULL
,	NULL
Watkins	NULL
P	NULL
,	NULL
Jones	NULL
EL	NULL
,	NULL
Morgan	NULL
A	NULL
,	NULL
Young	NULL
LS	NULL
,	NULL
Rooney	NULL
N	NULL
:	NULL
Latent	NULL
Epstein-Barr	NULL
virus	NULL
(	NULL
EBV	NULL
)	NULL
infection	NULL
in	NULL
cottotop	NULL
tamarins	NULL
:	NULL
A	NULL
possible	NULL
model	NULL
for	NULL
EBV	NULL
infection	NULL
in	NULL
humans	NULL
.	NULL

Am	NULL
J	NULL
Pathol	NULL
145:969	NULL
,	NULL
1994	NULL
32	NULL
.	NULL

Niedobitek	NULL
G	NULL
,	NULL
Young	NULL
LS	NULL
,	NULL
Lau	NULL
R	NULL
,	NULL
Brooks	NULL
L	NULL
,	NULL
Greenspan	NULL
D	NULL
,	NULL
Greenspan	NULL
J	NULL
,	NULL
Rickinson	NULL
AB	NULL
:	NULL
Epstein-Barr	NULL
virus	NULL
infection	NULL
in	NULL
oral	NULL
hairy	NULL
leukoplakia	NULL
:	NULL
Virus	NULL
replication	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
a	NULL
detectable	NULL
latent	NULL
phase	NULL
.	NULL

J	NULL
Gen	NULL
Virol	NULL
72:3035	NULL
,	NULL
1991	NULL
33	NULL
.	NULL

Niedobitek	NULL
G	NULL
,	NULL
Herbst	NULL
H	NULL
,	NULL
Young	NULL
LS	NULL
,	NULL
Brooks	NULL
L	NULL
,	NULL
Masucci	NULL
MG	NULL
,	NULL
Crocker	NULL
J	NULL
,	NULL
Rickinson	NULL
AB	NULL
,	NULL
Stein	NULL
H.	NULL
Patterns	NULL
of	NULL
Epstein-Barr	NULL
virus	NULL
infection	NULL
in	NULL
non-neoplastic	NULL
lymphoid	NULL
tissue	NULL
.	NULL

Blood	NULL
79:2520	NULL
,	NULL
1992	NULL
34	NULL
.	NULL

Gutierrez	NULL
MI	NULL
,	NULL
Bhatia	NULL
K	NULL
,	NULL
Magrath	NULL
I.	NULL
Replicative	NULL
viral	NULL
DNA	NULL
in	NULL
Epstein-Barr	NULL
virus	NULL
associated	NULL
Burkitt	NULL
's	NULL
lymphoma	NULL
biopsies	NULL
.	NULL

Leuk	NULL
Res	NULL
17:285	NULL
,	NULL
1993	NULL
35	NULL
.	NULL

Rowe	NULL
M	NULL
,	NULL
Lear	NULL
AL	NULL
,	NULL
Croom-Carter	NULL
D	NULL
,	NULL
Davies	NULL
AH	NULL
,	NULL
Rickinson	NULL
AB	NULL
:	NULL
Three	NULL
pathways	NULL
of	NULL
Epstein-Barr	NULL
virus	NULL
gene	NULL
activation	NULL
from	NULL
EBNA1l-positive	NULL
latency	NULL
in	NULL
B	NULL
lymphocytes	NULL
.	NULL

J	NULL
Virol	NULL
66:122	NULL
,	NULL
1992	NULL
36	NULL
.	NULL

Hamilton-Dutoit	NULL
SJ	NULL
,	NULL
Rea	NULL
D	NULL
,	NULL
Raphael	NULL
M	NULL
,	NULL
Sandvej	NULL
K	NULL
,	NULL
Delecluse	NULL
HJ	NULL
,	NULL
Gisselbrecht	NULL
C	NULL
,	NULL
Marelle	NULL
L	NULL
,	NULL
van	NULL
Krieken	NULL
JHJM	NULL
,	NULL
Pallesen	NULL
G	NULL
:	NULL
Epstein-Barr	NULL
virus-latent	NULL
gene	NULL
expression	NULL
and	NULL
tumor	NULL
cell	NULL
phenotype	NULL
in	NULL
acquired	NULL
immunodeficiency	NULL
syndrome-related	NULL
non-Hodgkin	NULL
's	NULL
lymphomas	NULL
.	NULL

Correlation	NULL
of	NULL
lymphoma	NULL
phenotype	NULL
with	NULL
three	NULL
distinct	NULL
patterns	NULL
of	NULL
viral	NULL
latency	NULL
.	NULL

Am	NULL
J	NULL
Pathol	NULL
143:1072	NULL
,	NULL
1993	NULL
37	NULL
.	NULL

Lucas	NULL
SB	NULL
,	NULL
Diomande	NULL
M	NULL
,	NULL
Hounnou	NULL
A	NULL
,	NULL
Beaumel	NULL
A	NULL
,	NULL
Giordano	NULL
C	NULL
,	NULL
Kadio	NULL
A	NULL
,	NULL
Peacock	NULL
CS	NULL
,	NULL
Honde	NULL
M	NULL
,	NULL
De	NULL
Cock	NULL
KM	NULL
:	NULL
HIV-associated	NULL
lymphoma	NULL
in	NULL
Africa	NULL
:	NULL
An	NULL
autopsy	NULL
study	NULL
in	NULL
Cote	NULL
d'Ivoire	NULL
.	NULL

Int	NULL
J	NULL
Cancer	NULL
59:20	NULL
,	NULL
1994	NULL
38	NULL
.	NULL

Fahraeus	NULL
R	NULL
,	NULL
Jansson	NULL
A	NULL
,	NULL
Ricksten	NULL
A	NULL
,	NULL
Sjoblom	NULL
A	NULL
,	NULL
Rymo	NULL
L	NULL
:	NULL
Epstein-Barr	NULL
virus-encoded	NULL
nuclear	NULL
antigen	NULL
2	NULL
activates	NULL
the	NULL
viral	NULL
latent	NULL
membrane	NULL
protein	NULL
promoter	NULL
by	NULL
modulating	NULL
the	NULL
activity	NULL
of	NULL
a	NULL
negative	NULL
regulatory	NULL
element	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
87:7390	NULL
,	NULL
1990	NULL
39	NULL
.	NULL

Henderson	NULL
S	NULL
,	NULL
Rowe	NULL
M	NULL
,	NULL
Croom-Carter	NULL
D	NULL
,	NULL
Wang	NULL
F	NULL
,	NULL
Long-necker	NULL
L	NULL
,	NULL
Kieff	NULL
E	NULL
,	NULL
Rickinson	NULL
A	NULL
:	NULL
Induction	NULL
of	NULL
bel-2	NULL
expression	NULL
by	NULL
Epstein-Barr	NULL
virus	NULL
latent	NULL
membrane	NULL
protein	NULL
1	NULL
protects	NULL
infected	NULL
B	NULL
cells	NULL
from	NULL
programmed	NULL
cell	NULL
death	NULL
.	NULL

Cell	NULL
65:1107	NULL
,	NULL
1991	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

blO	NULL
Od®	NULL
1995	NULL
86	NULL
:	NULL
659-665	NULL
Heterogeneous	NULL
expression	NULL
of	NULL
Epstein-Barr	NULL
virus	NULL
latent	NULL
proteins	NULL
in	NULL
endemic	NULL
Burkitt	NULL
's	NULL
lymphoma	NULL
4	NULL
_	NULL
5	NULL
,	NULL
'	NULL
_	NULL
>	NULL
,	NULL
#	NULL
04	NULL
;	NULL
©1004	NULL
@	NULL
207	NULL
G	NULL
Niedobitek	NULL
,	NULL
A	NULL
Agathanggelou	NULL
,	NULL
M	NULL
Rowe	NULL
,	NULL
EL	NULL
Jones	NULL
,	NULL
DB	NULL
Jones	NULL
,	NULL
P	NULL
Turyaguma	NULL
,	NULL
J	NULL
Oryema	NULL
,	NULL
DH	NULL
Wright	NULL
and	NULL
LS	NULL
Young	NULL
Updated	NULL
information	NULL
and	NULL
services	NULL
can	NULL
be	NULL
found	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/content/86/2/659.full.html	NULL
Articles	NULL
on	NULL
similar	NULL
topics	NULL
can	NULL
be	NULL
found	NULL
in	NULL
the	NULL
following	NULL
Blood	NULL
collections	NULL
Information	NULL
about	NULL
reproducing	NULL
this	NULL
article	NULL
in	NULL
parts	NULL
or	NULL
in	NULL
its	NULL
entirety	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
requests	NULL
Information	NULL
about	NULL
ordering	NULL
reprints	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/site/misc/rights.xhtml	NULL
#	NULL
reprints	NULL
Information	NULL
about	NULL
subscriptions	NULL
and	NULL
ASH	NULL
membership	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/site/subscriptions/index.xhtml	NULL
Blood	NULL
(	NULL
print	NULL
ISSN	NULL
0006-4971	NULL
,	NULL
online	NULL
ISSN	NULL
1528-0020	NULL
)	NULL
,	NULL
is	NULL
published	NULL
weekly	NULL
by	NULL
the	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
,	NULL
2021	NULL
L	NULL
St	NULL
,	NULL
NW	NULL
,	NULL
Suite	NULL
900	NULL
,	NULL
Washington	NULL
DC	NULL
20036	NULL
.	NULL

Copyright	NULL
2011	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
;	NULL
all	NULL
rights	NULL
reserved	NULL
.	NULL

